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Scaffold-based tissue engineering (TE) aims to aid in the repair and regeneration of 
bone defects. Bone defects due to high energy trauma, bone resections, congenital 
malfunction and severe non-union fractures require a bone substitute for regeneration. 
At present, the demand of most commonly used bone substitute autogenous cancellous 
bone grafts far exceeds the supply. Moreover, it is not an ideal solution due temporary 
disruption of donor site bone structure and considerable donor site morbidity associated 
with the harvest. Hence, the development of new synthetic bone substitutes or scaffolds 
that could be used instead of autogenous cancellous bone grafts has become a key 
priority in bone TE. 
In scaffold-based bone TE the scaffold acts as a platform to carry cells or 
therapeutic agents for regenerative therapies. An ideal scaffold is required to mimic the 
mechanical and biochemical properties of the native tissue. To effectively achieve these 
properties, a scaffold should be mechanically robust with suitable architectural qualities 
to favour flow transport of nutrient for cell growth. It should also have osteoconductive 
properties to support cells through suitable surface chemistry. In this context high 
performance extrusion based additive manufactured scaffolds were developed for bone 
tissue engineering by improving their mechanical, biochemical and cell seeding 
efficiency.  
Mechanical properties of the polymeric/ceramic scaffolds were improved by 
enhancing the interfacial interaction between the polymeric and ceramic phase through 
the use of coupling agents. Two different coupling agents, namely silane and POSS 
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have been used in this research project. The main idea of using a coupling agent was to 
improve the interfacial interaction between the ceramic and polymer phase. Both of the 
developed silanized poly (ε-caprolactone)/tricalcium phosphate (PCL/TCP) and POSS 
modified PCL/TCP scaffolds have significantly improved mechanical properties and 
are suitable to use for cancellous bone tissue engineering. No detrimental effect of 
silane modification was found on cells. On the other hand POSS modified scaffolds 
showed better proliferative capability compared to control PCL/TCP scaffolds, which is 
due to the exposed TCP on the POSS modified PCL/TCP scaffolds. 
To improve the proliferative and osteoconductive properties of the developed 
silanized PCL/TCP scaffolds, a thin layer of carbonated hydroxyapatite (CHA)-gelatin 
composite was coated onto the scaffolds by biomimetic co-precipitation process. In 
vitro studies showed promising results of the biomimetic composite coated scaffolds on 
proliferation and osteogenic differentiation of porcine bone marrow stromal cells. In 
vivo study was also conducted to evaluate the performance of biomimetic composite 
coated samples.  
To improve the functional performance of developed POSS modified PCL/TCP 
scaffolds by providing a cell entrapment system, a novel hierarchical scaffold that 
combines the advantageous properties of AM scaffold and porous foam scaffold was 
developed. In the hierarchical structure PCL/TCP(POSS)-foam scaffolds the macro-
sized PCL/TCP(POSS) filaments provide mechanical support and the porous gelatin 
foam structure formed by freeze drying acts as a cell entrapment system. From the 
manufacturing point of view, to fabricate hierarchical scaffolds, our developed 
approach is considerably simpler than combining electrospinning with AM. In vitro 
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results showed notably higher proliferative capability on PCL/TCP(POSS)-foam 
scaffolds compared to PCL/TCP(POSS) scaffolds.  
In summary, it has been found that coupling agents improve mechanical properties 
of the polymer/ceramic scaffolds significantly. Scaffolds with improved mechanical 
properties can be further modified to enhance functional performance of the scaffolds. 
This study will make a significant contribution in the field of extrusion based AM 
scaffolds by improving mechanical properties of the scaffolds by using coupling agents, 
and functional performance of the scaffolds by developing thin biomimetic composite 
coating and hierarchical structure for cells entrapment system. 
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Chapter 1  
Introduction 
1.1 Background 
The term tissue engineering (TE) is used to mean the replacement, repair, and/or 
regeneration of biological tissues and organs. This term was “coined” at a committee 
meeting at the National Science Foundation during the fall of 1987. This committee 
meeting led to the first congress called “tissue engineering,” which was held in early 
1988 at Lake Tahoe, California [1]. TE is an exciting idea which has experienced an 
explosive growth. It is an interdisciplinary field which combines the basis of life sciences 
and medicine with the methods of engineering. The purpose of TE is to develop a 
biological substitute that can replace, repair and/or improve tissue function. 
Scaffold-based tissue engineering (TE) aims to aid in the repair and regeneration of 
bone defects. Though bone is a highly regenerative organ, large bone defects due to high 
energy trauma, bone resections, congenital malfunction and severe non-union fractures 
require a bone substitute for regeneration [2]. In this aspect, the most practised solution 
is autografting which may not be very ideal due to its short supply, temporary disruption 
of donor site bone structure and considerable donor site morbidity associated with the 
harvest [3, 4]. Therefore, the development of new synthetic bone substitutes or scaffolds 
that could be used instead of autogenous cancellous bone grafts has become a key 
priority in bone TE [5-7]. 
In scaffold-based bone TE the scaffold acts as a platform to carry cells or 
therapeutic agents for regenerative therapies. An ideal scaffold is required to mimic the 
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mechanical and biochemical properties of the native tissue. To effectively achieve these 
properties, a scaffold should be mechanically robust with suitable architectural qualities 
to favour flow transport of nutrient for cell growth. It should also have osteoconductive 
properties to support cells through suitable surface chemistry [6]. 
Additive manufacturing (AM) technologies are fast becoming the technologies of 
choice for fabricating scaffolds for bone TE due to reliability, high degree of 
reproducibility and the potential to overcome the limitations of conventional manual-
based fabrication techniques [8]. Complex scaffold architecture designs based on a 
hierarchical approach can be readily fabricated through AM [9, 10]. Screw extrusion 
system (SES) which is a very promising AM technique has been used to fabricate both 
polymer and polymer/ceramic composite scaffolds with honeycomb like structure [11, 
12]. However, the focuses of the studies related to additive manufactured bone TE 
scaffolds are mostly limited to explore different fabrication techniques, optimize suitable 
porosity and pore size of scaffolds, and use of Ca-P type ceramics into polymer matrix to 
get improved mechanical properties. Hence, an important issue which has not yet been 
studied critically is using coupling agent to improve the mechanical properties of the 
composite scaffolds in context of bone TE. Moreover, different surface modification 
techniques to improve the proliferative and osteoconductive properties of the additive 
manufactured scaffolds are still in its infancy. 
1.2 Challenges in additive manufactured bone TE scaffolds 
In scaffold-based bone TE an ideal scaffold should be mechanically stable; that is 
the mechanical properties of the scaffold must be sufficient to withstand in vivo stress 
and loading [13] and the choice of material should have a degradation and resorption rate 
  Chapter 1. 
3 
so that the scaffold is retained until the fracture is remodelled by the host tissue [6]. 
Specially, it was proposed that the implanted scaffolds should match the stiffness and 
strength of native tissue at the time of implantation [6]. The scaffolds should also be 
biocompatible; that is the scaffolds must not evoke cytotoxicity and/or unresolved 
inflammatory response [6]. Moreover, it is desirable that the scaffolds should also be 
osteoconductive. Other highly desirable features concerning the scaffold are its 
controllable interconnected porosity and vascularization. Therefore, both the mechanical 
properties as well as the biochemical properties like biocompatibility and 
osteoconductivity of the scaffolds need to be considered to design and fabricate 
“potential” scaffolds for bone TE. 
To improve the mechanical properties of the polymeric scaffolds, ceramic particles 
have been mixed into the polymer matrix directly [12, 14]. However, only a slight 
improvement in compressive modulus and compressive strength was achieved with 
polymer/ceramic composite scaffolds compared with those of polymer scaffolds [14]. As 
reported recently in the review paper by Rezwan et al. [15] the limited improvement on 
mechanical properties of polymer/ceramic composite scaffolds is because of the 
relatively low interfacial bonding between ceramic particles and polymer matrix. Hence, 
using coupling agent to improve the interfacial bonding ceramic particles and polymer 
matrix which has been neglected in context of bone TE should be addressed with 
priority. 
Though there are many advantages of AM scaffolds, it has some inherent 
limitations. For example, the surfaces of the extrusion based AM scaffolds are generally 
smooth and hence it is difficult to coat with thin biomimetic composite within a short 
period of time. As a consequence, any efficient biomimetic coating approach for AM 
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scaffolds has not yet been reported. Moreover, the cell seeding efficiency of AM 
scaffolds are poor. To improve the cell seeding efficiency a combinational approach by 
combining both AM and electrospinning has been introduced. Though the hybrid 
scaffolds resulted by AM technology with electrospinning are promising, more efforts 
are needed in the insulation of the AM robot from the electrospinning high voltage 
collector [16]. Therefore, a simple combinational approach should be developed to 
improve the cell seeding efficiency, and thereby to improve the functional performance 
of the scaffolds. The hypothesis, objectives and significance of this research will be 
elaborated in the following sections. 
1.3 Research hypothesis and objectives 
Having the above mentioned challenges in mind the following hypothesis can be 
formed:  
“To further improve the range of bone TE applications we need to improve the 
mechanical and functional performance of extrusion-based additive manufactured 
scaffolds.” 
The main objective of this study was therefore to develop additive manufactured 
scaffolds with improved mechanical and functional performance for bone TE 
applications. In this context, a number of objectives that have been set to accomplish the 
principal aim are as follows: 
¾ Evaluate the suitability of in-house screw extrusion based AM technology 
to fabricate polymer-ceramic composite scaffolds for bone TE. 
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¾ Modify polymer/ceramic composite with different coupling agents, and 
then evaluate the developed composite by fabricating extrusion-based AM 
scaffolds in terms of mechanical properties and biocompatibility. 
¾ Improve the proliferative and osteoconductive properties of the developed 
scaffolds by giving composite coating through biomimetic co-
precipitation process. 
¾ Develop a combinational approach to improve the cell seeding efficiency 
of the developed scaffolds. 
¾ Evaluate the biomimetic composite coated scaffolds in rat calvarial 
defect. 
1.4 Significance of the research 
The results of this present study may have significant impact on the application of 
scaffolds in bone TE application by providing additive manufactured scaffolds with 
improved mechanical and functional performance. The results may particularly 
contribute to the better understanding of the effects of different coupling agents on 
polymer/ceramic composites for bone TE application. Furthermore, the results may 
extend the understanding of the basic principles to give effective biomimetic coating on 
additive manufactured scaffolds and also different ways to improve functional 
performance of additive manufactured scaffolds for bone TE. 
In this research poly (ε-caprolactone)/tricalcium phosphate (PCL/TCP) has been 
taken as a benchmark in the field of additive manufactured bone TE scaffolds. The 
reason of the huge popularity of PCL in the field of biomaterials is due to its versatility 
in applications ranging from sutures to wound dressings, artificial blood vessels, nerve 
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regeneration, drug-delivery devices and bone engineering applications. Many PCL based 
drug-delivery and medical devices have FDA approval and CE Mark registration. 
Another important feature of PCL is it does not have any acidic degradation like 
poly(lactic acid) (PLA) and poly(lactic-coglycolide) (PLGA). However, it is hoped that 
the developed methods during this research could be translated to other aliphatic 
polyester based polymer like poly (lactic acid) (PLA) and poly (lactic-co-glycolide) 
(PLGA) if needed. 
1.5 Structure of thesis 
There are eight chapters and one appendice in this thesis. This chapter started with 
the importance and present challenges of additive manufactured scaffolds for bone TE, 
and ends up with the hypothesis, aim and significance of this research work. 
Chapter 2 presents a comprehensive review on additive manufactured scaffolds for 
bone TE by describing design, materials and fabrication technologies used for scaffolds. 
Moreover, the recent challenges with additive manufactured scaffolds for bone TE is 
highlighted with simplicity. 
Chapter 3 describes the main features and interdependence of the different process 
parameters of in house SES. The methodological evaluation of this in house SES 
fabricated scaffolds is also discussed. 
Chapter 4 presents a comprehensive study of using different coupling agents to 
enhance the mechanical properties of the scaffolds. 
Chapter 5 describes and evaluates a biomimetic composite coating process on 
previously developed additive manufactured scaffolds. 
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Chapter 6 describes a combinational approach by combining AM and freeze drying 
to improve the cell seeding efficiency of the scaffolds. 
Chapter 7 evaluates the performance of the biomimetic composite coated additive 
manufactured scaffolds in rat calvarial defect. 
Chapter 8 consists of conclusions and contributions of the research work. In 
addition, some directions for future work related to this study are also given. 





Many patients who are in need of organ transplantation suffer greatly due to the lack 
of suitable donors. At present, the demand for replacement organs far exceeds the 
supply. In addition, many bone grafting procedures are carried out worldwide on a daily 
basis, which although effective, are not ideal solutions. Scaffold-based tissue engineering 
(TE) aims to aid in the repair and regeneration of bone defects. Using this approach, the 
scaffold acts as a platform which carries cells or therapeutic agents for regenerative 
therapies. To achieve this, a scaffold should have some desirable properties. In general, 
the most important thing is biocompatibility; that is the scaffolds must not evoke 
cytotoxicity or unresolved inflammatory response [6]. In addition, it should be 
mechanically stable; that is the mechanical properties of the scaffold must be sufficient 
to withstand in vivo stress and loading [13] and the choice of material should have a 
degradation and resorption rate so that the scaffold is retained until the fracture is 
remodelled by the host tissue [6]. Specially, it was proposed that the implanted scaffolds 
should match the stiffness and strength of native tissue at the time of implantation [6]. 
Other highly desirable features concerning the scaffold are its controllable 
interconnected porosity and vascularization. 
This chapter aims to identify the state-of-the art and future direction of additive 
manufactured bone TE scaffold. The emphasis will be on the design, material and 
additive fabrication of the bone TE scaffolds.  
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2.2 Background of scaffold technology 
When we face the failure of a vital organ, we may need replacement. The 
replacement can be a transplant from another person or it can be an artificially produced 
organ. If we are unable to find a replacement then it may cause severe disability or even 
death. However, the use of transplantation faces problems like immunorejection and 
currently the demand for organs far exceeds the supply. Therefore, the necessity of 
creating artificial organs in the laboratory increases day by day. Though there are still 
many years to go before a doctor can order a ready-made organ, with the advancement in 
TE or regenerative medicine and biomanufacturing, we should eventually be able to 
achieve the “functional spare part”.  
TE is an interdisciplinary field.  It combines the basis of life sciences and medicine 
with the methods of engineering. “The goal of TE is to go beyond the limitations of 
conventional treatments based on organ transplantation and biomaterial implantation 
[17]”. TE has three basic components and these are the cells, scaffolds and signals. From 
Figure 2.1 it can be seen that cells are collected from patients (they can also be collected 
from some other persons) and then cultured in a 3D environment. Sometimes a suitable 
environment is provided through bioreactors. After a certain period scaffolds are 
transplanted to the desired location.  
The therapy of TE can be done with the cultivated cell or it can be done by 
production of tissue constructs. To create tissues in vitro, the respective cells have to be 
settled on a natural or artificial extra cellular matrix (ECM). This construct is called a 
scaffold. Study into scaffolds is currently one of the important issues in TE.  Scaffolds 
act as a temporary support for cells to attach, proliferate and differentiate. They 
coordinate the growth of tissues in a desired shape.  The scaffolds are then cultured with 
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cells, which are grown in a controlled environment. Figure 2.2 illustrates the 
interdependency of three broad areas of scaffold technology; design, biomaterials and 
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2.3 Design of scaffolds 
2.3.1 Porosity and pore size of scaffolds 
Porosity and pore size are two important structural features of scaffolds that have 
considerable effect on cell growth. The pores of the scaffold should be connected to 
promote nutrient supply and tissue growth. In vitro, lower porosity stimulates 
osteogenesis, whereas, in vivo higher porosity and pore size result in greater bone 
ingrowth [18]. Different types of cells need different pore sizes for optimum growth and 
it was found that chondrocytes and osteoblast type cells grow better within the pore size 
of 380-405 μm [19]. Works related to porosity and pore size are comprehensively 
reviewed by Karageorgiou et al. [20]. They have noted that 100 μm pore size is essential 
for cell migration and transport, and a recommended pore size of greater than 300 μm is 
better for increasing the formation of new bone and capillaries. The reason appears to be 
that osteogenesis progression is affected by pore size.  Small pores induce osteochondral 
formation before osteogenesis, whilst large pores that are well vascularized induce direct 
osteogenesis. 
Tissue forms quickly on the outer surfaces of the scaffold and this phenomenon 
hinders cell penetration and nutrient exchange to the scaffold core. This problem can be 
addressed by building scaffolds with both random and anisotropic open porous 
structures. Graded porosity has its importance in multiple tissue interface regions such as 
in articular cartilage/bone transplant [21]. Figure 2.3(a) shows a gradient porosity 
scaffolds by varying different filament to filament distance while keeping the lay down 
pattern constant [22]. Biphasic scaffolds showed potential in the repair of large 
osteochondral defect [23]. In this perspective, we are proposing a novel functionally 
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graded hybrid scaffolds. With this concept it would be possible to tailor both bone and 
cartilage phases into one implant. Therefore, it will reduce the complexity in handling 
and the surgery will be more efficient. Moreover, this multi-phasic constructs will 
provide new strategies for tissue repair.  The schematic of the hybrid construct is given 





Figure 2.3 Graded scaffolds (a) with controlled porosity with varying pore geometry via 
FDM [8]; (b) proposed hybrid scaffolds by our group, where zone i: bone phase, 
PCL/20%TCP with 65-70% porosity; zone ii: bone plate phase, PCL/20%TCP with 30-
40% porosity; zone iii: calcified cartilage phase, PCL/10%TCP with 70-75% porosity 
and zone iv: cartilage phase, PCL with 70-75% porosity. 
2.3.2 Architecture of scaffolds 
Although AM scaffolds can be 100% interconnected and highly porous with very 
regular structure, previous study also reported less cells and tissue penetration within 
interior of the additive manufactured scaffolds [14]. Figure 2.4(A) shows the traditional 
structure fabricated by extrusion based AM technology. At the middle of this structure 
cells grow in a limited manner or even die during cell culture due to the lack of nutrient 
supply. To solve this problem we have proposed the structure having a through hole for 
nutrient supply as shown in Figure 2.4 (B, C). As well as possibly improving the 
mechanical properties of a scaffold, it is conjectured that through-holes may also become 
useful to increase the mass transport of oxygen and nutrients deep within and removal of 
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of nutrients or growth factors. Some recent studies have also introduced through holes in 
scaffolds fabricated using other AM technologies like 3-dimensional printing (3DP) [24] 
and stereolithography (SLA) [25] to improve the mass transport of oxygen and nutrients. 
However, validation of the usefulness of these through holes or macro channels during in 





Figure 2.4 Schematic of (a) traditional scaffold fabricated by FDM type system, (b) 
structure proposed by us for channeling and (c) SEM images of the structure for 
channeling or storage of nutrients [88]. 
Architecture of the AM scaffolds has also been designed to improve the cell seeding 
efficiency of the scaffolds. In extrusion based scaffolds different lay down patterns of the 
extruded filaments were used to improve the cell seeding efficiency of the scaffolds [26]. 
By varying the angle of the lay down pattern in successive layers a spirally convoluted 
porous scaffold can be fabricated [22]. Scaffolds designed with inclined layers of 45º 
have been fabricated (as shown in Figure 2.5 ) using 3DP to improve the cell seeding 
efficiency [27]. Eventually, this design enhanced cell attachment because the cells are 
hindered from sliding down the structure during static cell seeding process. These 
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internal structures and high resolution were fabricated using 3DP [27, 31]. In vitro results 
showed that the cells proliferated deep into the fabricated scaffolds proving the potential 
of 3D printed HA scaffolds. HA scaffolds fabricated through FDM has also shown good 
biocompatibility as indicated by a dense covering of human osteoblast sarcoma cells 
after 48 hr of in vitro study [32]. Indirect fabrication using casting in AM moulds 
provides another way to fabricate ceramic scaffolds with controlled structure [33, 34]. 
However, the indirect fabrication has the shortcoming of increased scaffold fabrication 
time compared with direct methods. 
At present the use of pure HA and TCP scaffolds are limited especially for the 
applications involving large skeletal defects because of their brittleness and propensity to 
fracture. Eventually the ceramic scaffolds failed to combine good mechanical properties 
with an open porosity [18], which restricted its use from medium to high compressive 
loading. 
2.4.2 Biodegradable polymer matrices 
There are two types of biodegradable polymers: natural polymer and synthetic 
polymer. Natural polymer includes polysaccharides (starch, alginate, chitin, hyaluronic 
acid derivatives) and proteins (soy, collagen, fibrin gels). Among these natural polymers 
chitosan, collagen, gelatin and starch have been used successfully to fabricate AM bone 
tissue engineered scaffolds [35-40]. Chitosan is deacetylated derivative of chitin, the 
second most abundant natural polymer after cellulose, commonly found in shells of 
crustaceans and cell walls of fungi [41]. Interesting properties that enable the linear 
polysaccharide chitosan as a bone scaffold material are its unique cationicity, intrinsic 
antibacterial nature, minimal foreign body reaction and suitable gelling properties [41-
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44]. Geng et al. [38] have fabricated porous chitosan scaffolds using an extrusion-based 
AM technology, which sequentially dispenses sodium hydroxide solution, and chitosan 
dissolved in acetic acid resulting in gel-like chitosan scaffolds. To get hydrated scaffolds 
first the scaffolds were thoroughly washed, heated at 40 ºC followed by freeze drying. 
The fabricated chitosan scaffolds showed good biocompatibility. Porous structure 
prepared by functionalized photo curable chitosan showed very good endochondral 
ossification upon implantation [39]. In line with this development of functionalizing 
natural polymers, a successful use of photo curable gelatin to fabricate scaffolds made by 
SLA should be noted [37]. It should be mentioned here that collagen-based gelatin has 
many of biological functional groups, and as gelatin is denatured, it overcomes the risk 
of immunogenicity that is associated with collagen. In vitro cell culture of methacrylate 
functionalized gelatin scaffolds reported no cytotoxicity which signifies the 
biocompatibility of developed monomer. Lam et al. were the first group to demonstrate 
the use of natural polymers to fabricate scaffolds by 3DP [40]. They have used starch 
based polymer powder (cornstarch, dextran and gelatin) as the scaffold material and 
water as the binder. Starch and dextran, which are both polysaccharides, have been 
shown to be biocompatible [40, 45]. On the other hand using water as the binder 
eliminates the risk involved in the residual solvent and also opens up the possibility of 
using biological agent during the scaffolds fabrication process by 3DP.  
The most widely used biodegradable synthetic polymers from the past decade for 
bone TE scaffolds are saturated poly-α-hydroxy esters, including poly(lactic acid) (PLA) 
and poly(glycolic acid) (PGA), as well as poly(lactic-coglycolide) (PLGA) copolymers 
[15]. These polymers are easily processable into a variety of architectures and shapes 
with a wide range of tailored mechanical and degradation properties by using the 
monomer ratios in lactide/glycolide copolymers [6]. PLLA scaffolds with degradation 
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rate appropriate for bone repair has been fabricated through extrusion based AM 
technology [46]. However, the disadvantage of polylactone type polymer is 
accumulation of acidic matter while degrading, and thus the abrupt release of these 
acidic degradation products can be a cause of inflammation of the surrounding tissue [47, 
48].  
PCL is another important aliphatic polyester which possesses superior rheological 
and viscoelastic properties over many of its resorbable-polymer counterparts, and hence 
it is very easy to fabricate and manipulate into a large range of AM bone TE scaffolds 
[49-51]. At National University of Singapore researchers have developed and patented 
the parameters necessary to process medical grade PCL by FDM. These scaffolds have 
been extensively studied clinically for more than 5 years and gained Food and Drug 
Administration (FDA) approval in 2006 [49, 52]. However, PCL is hydrophilic and its 
degradation rate is very slow. To vary the ratio of hydrophobic/hydrophilic constituents 
by copolymerization and to modulate degradability polyester-polyether block co-
polymers composed of PCL or PLA and poly (ethylene glycol) (PEG) have been studied 
[53-55]. To enhance hydrophilicity and control degradability PEG and PLA has been 
added into PCL main chain, respectively. Study demonstrated that PEG-PCL-PLA co-
polymer is suitable for fabricating scaffolds with honeycomb like structure having 
completely interconnected and controlled pore channels by extrusion based AM 
technology. In vitro cell study using primary human fibroblasts also showed 
biocompatibility of the developed co-polymer [54]. 
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2.4.3 Polymer/ceramic composite scaffolds 
Recently composite materials have been investigated comprehensively as they have 
the potential to harness the advantageous properties of both polymer and ceramics 
(mainly Ca-P), and thereby improve the biochemical and mechanical properties of the 
bone tissue engineered AM scaffolds [12, 14, 15, 18, 56-61]. Polymer/ceramic composite 
scaffolds showed more apatite coating formation [62] and improved cellular response 
[12] compared to polymeric scaffolds. Polymer/ceramic composite scaffolds also showed 
more hydrophilicity during contact angle measurements [14] and favourable degradation 
and resorption kinetics compared to polymeric scaffolds. Incorporation of Ca-P based 
ceramic into the fast degrading aliphatic polyester like poly (L,L-lactide-co-glycolide) 
(PLGA) helps to neutralize the acidic resorption by-product of the polyester, and thus 
aids to circumvent the formation of harsh environment for the cells due to decreased pH 
[63]. 
Polymer/Ca-P composite scaffolds have improved mechanical properties as it 
improves strength via the ceramic phase and toughness and plasticity via the polymer 
phase. However, a crucial aspect is the interfacial bonding between the ceramic and 
polymer phase which has been ignored in the development process of composite material 
for bone TE scaffolds and therefore the improvement on mechanical properties of 
polymer/ceramic scaffolds is limited [15, 18]. The particle size of Ca-P and distribution 
in the polymer matrix have been identified as important aspects to improve mechanical 
properties [64]. Apparently, an increased volume fraction of the Ca-P filler into the 
polymer matrix also leads to stiffer scaffolds [61]. However, during mechanical loading 
failure can preferentially occur at the interface of ceramic and polymer matrix. 
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Therefore, improving the interfacial bonding between the ceramic and polymer phase to 
improve the mechanical properties of the scaffolds are imperative. 
2.5 Fabrication of scaffolds 
2.5.1 Conventional fabrication techniques 
The basis of conventional scaffold fabrication techniques are textile and polymer 
processing technologies. Conventional fabrication techniques include solvent casting 
particulate leaching, gas foaming, fiber meshes/fiber bonding, phase separation, melt 
molting, freeze drying and solution casting [8]. Each of these techniques has limitations 
to precisely control pore size, pore geometry, pore interconnectivity and spatial 
distribution of pores. These techniques are mostly manual, labor intensive and time 
consuming, which results in inconsistent macro and micro structure. This could lead to 
partially connected pathways, which hampers the supply of nutrients and the ingrowth of 
tissue into the scaffold [65]. Besides these limitations, most of the conventional 
techniques usually involve extensive use of toxic organic solvents in order to convert raw 
material into the final scaffolds. Residual solvents in the scaffolds especially in thicker 
constructs lead to detrimental effect on cells and / or nearby tissues [8]. In this context 
additive manufacturing technology which is a computer controlled fabrication process, 
reveals a great potential by offering design dependent scaffolds, as opposed to the 
process dependent scaffolds offered by conventional techniques [8, 9, 65-70]. 
2.5.2 Additive manufacturing techniques 
Additive manufacturing refers to a group of techniques that can generate a physical 
model in a layer-by-layer manner directly from computer aided design data. Over the 
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past two decades more than 20 additive manufactured techniques have been developed 
with an effort focused on the rapid manufacturing of prototypes for non-biomedical 
applications, and these techniques separate themselves mainly by the method by which 
the layers are laid down, solidified and attached to the previous one [8, 9, 67]. Though 
there are variants in additive manufacturing based on the way they build up the 3D 
model, they all have three basic steps: data input, data file preparation and structure 
building. In particular in a medical context, for a patient specific physical model, the 
input data is captured by computed tomography (CT) or magnetic resonance imaging 
(MRI) scans and this patient specific data is used to generate a computer based 3D model 
by computer aided design (CAD) software. This 3D CAD model is then imported into 
AM system software to be sliced into thin horizontal layers with specified tool paths for 
each layer. Successively the data are implemented by the additive manufacturing 
machine that creates the customized physical model. Today AM technologies have been 
used extensively to fabricate bone tissue engineering scaffolds with customized external 
shape and predefined internal morphology with full control of pore size and pore 
distribution. Some important AM techniques include stereolithographiy apparatus (SLA), 
selective laser sintering (SLS), 3D printing and extrusion based processes, which will be 
discussed in the following sections. 
2.5.2.1 Stereolithographiy apparatus (SLA) 
SLA was the first commercially available AM system introduced by 3D System in 
1986. (www.3dsystems.com). The manufacturing of 3D objects by SLA is based on 
selective polymerization of a liquid photo curable monomer by an ultraviolet laser beam. 
With the computer guided laser beam a pattern is illuminated on the surface of liquid 
photo curable monomer in accordance with the CAD data. As a result of this 
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illumination, polymerization occurs and the liquid solidifies to a certain depth. After the 
first layer is built, the platform holding the model is moved down from the surface into 
the vat and the built layer is submersed with liquid resin. A pattern is then cured in this 
second layer. The procedure is repeated until the model is completed. After that the 
model is removed from the platform, washed of excess resin and cured in a UV oven and 
finished by smoothing the surface irregularities. SLA has the highest accuracy and 
resolution among all the AM technologies which can build objects that measure several 
cubic centimetres at an accuracy of 20 μm, whereas most other AM techniques build 
objects with an accuracy of 50-200 μm in size [71]. However, to date the use of SLA in 
biomedical industry is mainly focused on building anatomical models for surgical 
planning [72].  
Poly (propylene fumarate) (PPF) is the most comprehensively studied biodegradable 
and photo-crosslinkable polymers [73] because of its convenient photo-crosslinking 
characteristics and suitable mechanical properties after UV crosslinking. Composite 
structure can also be fabricated using SLA. PPF-HA composite structures was fabricated 
by mixing PPF and HA particles in diethylfumarate (DEF) [74]. Protein binding 
molecules biotin has also been immobilized by excimer laser photobiotin. Furthermore, 
HA scaffolds with well-defined channel size and desired connection pattern can be 
fabricated with indirect SLA technique [33]. Eventually this is a lost-mold technique 
where SLA was used to create negative molds and a highly loaded curable HA 
suspension was used as the ceramic carrier. Most interestingly some recent studies 
showed promising results on synthesizing a series of photocurable natural polymers, 
which eventually extends the use of natural polymer in SLA techniques [37, 39].  
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Despite these achievements, till today, the limited number of commercially 
available resins can be considered as the main limitation of SLA technique. Moreover, 
the technique is still limited to the use of a single resin at a time, whereas 3D printing 
and extrusion based system allow the fabrication of scaffolds with different materials 
simultaneously by using multiple cartridges [71]. 
2.5.2.2 Selective laser sintering (SLS) 
SLS technique normally uses a CO2 laser beam to selectively sinter thin layers of 
powdered materials following the cross-sectional profiles carried by the slice data to 
form 3D objects. The interaction of the laser beam with the powder raises the powder 
temperature to its glass transition temperature, which causes particles to fuse together in 
a small layer. After finishing each layer a new layer of powder is supplied using a 
mechanical roller. Each new layer bonds to those previously sintered layers also because 
of the sintering process [75]. 
SLS showed great potential in producing complex porous ceramic matrices suitable 
for implantation in a bone defect [76, 77]. However, theoretically SLS is suitable to use 
any powdered biomaterial which fuses but not decomposes under a laser beam. Powder 
blends of polyetheretherketone (PEEK) and PEEK-HA has been sintered on SLS by 
varying various process parameters like the part bed temperature, laser power and scan 
speed [78]. This study showed promising results on laser sintering a high melting point 
unconventional biopolymer PEEK in lower temperature environment and demonstrated 
that a low part bed temperature should be complemented by a higher laser power. This 
study also demonstrated that the wt% of HA in PEEK should not exceed 40% in order to 
make a structure with good integrity. SLS has also been used to fabricate bioresorbable 
polymers or composites structures or scaffolds [50, 57-59, 79-82]. Williams et al. have 
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demonstrated the potential of SLS to fabricated PCL scaffolds [50]. They have designed 
PCL scaffolds computationally and then fabricated via SLS. The fabricated PCL 
scaffolds were implanted subcutaneously in mouse with BMP – 7 transduced fibroblasts. 
The in-vivo histological evaluation and micro-computed tomography (mCT) analysis of 
implanted scaffolds demonstrated the generation of bone. In addition to the fabrication of 
bioresorbable polymer scaffolds, polymer-ceramic composite scaffolds have also been 
fabricated [57, 79, 82]. Wiria, F. E. et al. [57] have investigated the feasibility of 
fabricating PCL/HA scaffolds by SLS. They have also investigated the process 
parameters on the sintering effect of the constructs. By observing the necking, porous 
network formation and also on the basis of handling stability of the construct they have 
determined some preferred parameters. They noticed that sintering of the PCL/HA 
composite is more difficult than sintering PCL alone because of the addition of HA 
powder, although the sintering result was good.    
In SLS process volumetric absorption of the laser radiation by the polymer leads to 
melting of the whole polymer particle, which eventually decreased the possibility of 
using bioactive molecule during the fabrication process. To overcome this limitation, a 
modified SLS process – surface selective laser sintering (SSLS) has been introduced 
[83]. In this modified process initiation of sintering starts only by melting the surface of 
polymer particle. To achieve this PLA, which does not absorb near-infrared laser 
radiation, has been modified with biocompatible carbon particles and only these carbon 
particles absorb laser radiation which leads to the localized sintering. This “gentle” 
process improves the probability of incorporating bioactive molecules during the SLS 
scaffold fabrication process [83]. 
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Despite these advancements and advantages offered by SLS, there are some 
limitations. For example, SLS fabricated structures are limited to the smaller pore size 
ranges (<50 μm). Moreover, as this process involves high processing temperature, it is 
mainly suitable to thermally stable polymers [8].  
2.5.2.3 Three-dimensional printing (3DP) 
3DP technique was developed at Massachusett Institute of Technology (MIT) by 
Sachs et al. in 1993 [84] and today it is a popular technique to fabricate tissue 
engineering scaffolds. This technique is based on ink jet printing technology for 
processing powder materials. During fabrication, a printer head is used to deposit or print 
a stream of binder solution over the surface of a powder bed following the object’s 
profile as generated by the system computer. After finishing the 2D layer, a fresh layer of 
powder is laid down. The layers merge together due to the next cycle of binder solution 
until the whole part is completed. The completed 3D object is collected by removing the 
unbound powder.  
3DP has been used widely to fabricate tissue engineering scaffolds for its simplicity 
[31, 35, 40, 85-90]. This technique operates at room temperature, and there by suitable 
for processing temperature sensitive materials especially natural biopolymers. Lam et al. 
have demonstrated the feasibility of using natural biopolymers by 3DP with a blend of 
starch based powder containing cornstarch, dextran and gelatin, bounded by distilled 
water [40]. It is interesting to mention that as the binder is water, and therefore this 
process eliminats the problem linked to the use of an organic solvent. However, to 
enhance the mechanical stability of the scaffolds and also to decrease the solubility in 
water a long post processing was necessary. Collagen scaffolds with complex internal 
morphology and macroscopic shape has also been fabricated by indirect 3DP using a 
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sacrificial mould [35]. In addition, ceramic scaffolds have successfully been fabricated 
using 3DP [31]. Ceramic scaffolds fabricated using this technique showed higher 
compressive strength and larger pores compared to the conventionally sintered calcium 
polyphosphate scaffolds of similar porosity [90]. 
 Limited pore size (<50 μm) is one of the disadvantage of 3DP. Larger pore can 
be created in 3DP scaffolds by mixing porogens into the powders prior to the fabrication 
process [85, 86]. However, incomplete leaching of porogen can lead to residues. 
Moreover, as 3DP structures are powder supported and become powder filled due to the 
unbound powder, there is difficulty in removing internal unbound powder.  
2.5.2.4 Extrusion based system 
In 1992 Crump developed the first commercially available extrusion based system 
known as fused deposition modeling (FDM) [91]. In this system, a thin thermoplastic 
filament is melted by heating and the semi molten material comes out through an orifice 
while it is guided by a robotic device. The extruded material cools, solidifying itself and 
fixing to the previous layer [92]. Successive layer formation on top of another layer 
forms the desired 3D porous structure. Porosity of the structure varies in the XY plane 
and Z direction. The porosity in the XY plane is created by controlling the distance 
between two adjacent filaments, while porosity in the Z direction mainly governed by the 
diameter and lay down angle of the extruded filament [67].    
FDM has been used extensively to fabricate scaffolds with a reasonable range of 
channel size, filament diameter and porosity [93, 94]. Highly interconnected and 
reproducible bioresorbable structure can be fabricated with FDM. However, the 
commercial FDM system requires the material in the form of filaments with specific size 
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and material properties to ensure regular material flow and the fabrication of the regular 
structure.  This imposes a limitation on the processing window and the number of 
materials that can be explored for higher load bearing applications. 
 To minimize costs and to permit use of a wider range of materials, a compressed-
air extrusion system was developed [54, 55] (shown in Figure 2.6(B)).  However, in such 
a system it is difficult to go beyond a certain pressure due to the complexity of the 
required valve system.  As a result, the limited pressure would require materials with 
suitable melt-flow properties and it may not be possible to create structures suitable for 
high/medium load bearing applications.  Also, the possibility of entrapped air bubbles in 
the polymer melt may result in imperfect filament deposition and parts with poor 
mechanical properties [95]. 
To overcome such disadvantages and to further widen the range of possible 
materials a screw-extrusion system can be used (as shown in Figure 2.6 (C)).  The screw-
extrusion system (SES) consists of a robotic-arm, barrel and heater as like the 
conventional FDM machine.  The robotic arm enables movement of the barrel in the x-y-
z directions.  The heater melts the material, which is then extruded by pressure using a 
turning screw feed [11, 12, 92, 96].  The parameters which would determine the quality 
of the extruded scaffolds include the motor speed, dispensing speed, the melt 
temperature, the platform temperature, layer thickness, nozzle size and road width [92, 
95]. In a wider perspective understanding different process parameters relating to the 
scaffolds fabrication process is very important. Hence, computational studies of different 
process parameters like melt flow behavior, pore size, porosity of extrusion based system 
have been done [92, 97, 98]. 
 









Figure 2.6 Graphical illustrations of (A) the conventional FDM system (B) compressed 
air extrusion system (C) screw-extrusion system [86]. 
  In the developmental process of extrusion based system combining two extrusion 
systems can be a potential fabrication technique to use different material from hydrogel 
to polymeric/ceramic composite. Thus combining two extrusion systems in a single robot 
facilitates the fabrication of multiple material scaffolds. In this context the Polytechnic 
Institute of Leiria has developed a variation of FDM consisting of two different extrusion 
systems; one rotational system for multi material deposition acted by a pneumatic 
mechanism and another one for a single material deposition system that uses a screw to 
assist the deposition system [65]. Multiple material scaffolds can also be fabricated with 
low temperature deposition modeling (LDM) under 0 ºC, and this technique fabricates 
scaffolds with hierarchical macro and micro pores by integrating extrusion and phase 
separation [99-101]. To fabricate scaffolds through LDM, at first the material was 
dissolved into solvent at room temperature and then extruded into a low temperature 
refrigerator to fabricate frozen scaffolds with macropores. After that the scaffolds were 
freeze dried to evaporate residual solvent which eventually creates micropores. 
Extrusion based system has also been using in the area of cell printing. This 
technique is offering a great potential in the field of organ printing by printing gels, 
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single cells and cells aggregate [102, 103]. Scaffolds fabricating by extrusion based 
system has also been using in the field of cancer research [104]. 
Despites the credibility of extrusion based system, it has some limitations. As an 
example, the pore openings for the scaffolds are not consistent in all three dimensions. 
The seeding efficiency of the extrusion based scaffolds is limited. To improve the cell 
seeding efficiency of the extrusion based scaffolds combinational approaches have been 
taken, which will be discussed in the following paragraph. Besides these limitations, in-
general the extrusion based scaffolds have a smooth surface which is not suitable for 
initial cell attachment. To overcome this, surface roughness has been incorporated with 
the aid of a piezoelectric vibration system [105]. In this process well-aligned wavy 
shaped surface roughness was formed along the direction of plotting with a vibration 
depth and period of 0.9 μm and 50 μm, respectively. The surface-modified 3D extrusion 
based scaffold exhibited enhanced mechanical property and improved initial cell 
attachment and proliferation compared to conventional extrusion based scaffolds. 
2.6 Modification of scaffolds 
2.6.1 Through combinational approach  
Only a few number of additive manufacturing technologies has been used in clinical 
area, though these technologies are notably successful in overcoming the hurdle of 
desired complex scaffolds architecture. Therefore, still there is enough room to develop 
“smart scaffolds”, even from a scaffold design and manufacturing point of view. In this 
aspect combining different scaffolds fabrication techniques to fabricate scaffolds are 
gaining much interest [106]. As we know extrusion based additive manufactured 
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scaffolds have a poor cell seeding efficiency due to limitation in scaffold’s pore 
resolution. To overcome this problem a hybrid scaffold structure combining an extrusion 
based scaffolds fabrication technology with electrospinning has been proposed [107, 
108]. The resulting hybrid structure consisting of macro sized strands and micro sized 
filaments which give mechanical support and enhance the cell entrapment efficiency of 
the hybrid scaffolds, respectively. Though the hybrid scaffolds resulted by combining the 
extrusion based scaffolds fabrication technology with electrospinning are very promising 
in the field of tissue engineering, more efforts are needed in the insulation of the additive 
manufacturing robot from the electrospinning high voltage collector [16]. Hence, hybrid 
scaffolds developed in our lab by combining conventional freeze drying technology with 
extrusion based scaffolds fabrication technology may be considered as a simple and 
effective manufacturing approach (described in chapter 6).  
Surface topography like micro pores which play an important role for pheonotypic 
expression of osteoblast like cells [109], are difficult to obtain and control in the additive 
manufactured scaffold. This limitation can be addressed by integrating traditional 
porogen technique with the additive manufacturing technique [110]. To fabricate the 
desired scaffolds, at first, the mold was created by additive manufacturing and thereafter, 
the mold was filled with slurry material followed by drying and high temperature 
treatment. At high temperature the resign mold and porogen decomposes thermally 
leaving behind the desired scaffolds with interconnected macro pores and micro pores 
throughout the entire surface of the scaffolds.  
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2.6.2 Through surface modification 
From the previous discussions it can be said that there has been significant research 
on the architecture, porosity and pore size of the additive manufactured scaffolds with 
pore dimensions and material properties being vital in promoting cell proliferation and 
de novo production of extracellular matrix. However, making scaffold surfaces more 
biocompatible and/or combining bioactive molecules are comparatively recent trends 
towards the development of next generation additive manufactured scaffolds for bone 
tissue engineering [52].  
 It is a common hypothesis that a bone like apatite layer bound to the surface of 
the scaffolds could be useful in bone tissue engineering. To provide an apatite coating 
through simulated body fluid (SBF) on the additive manufactured PCL scaffolds, the 
PCL scaffolds were treated with NaOH to provide carboxylate groups onto the surface 
and then dipped in aqueous CaCl2 and K2HPO4.3H2O alternately to deposit apatite nuclei 
on the surface. A dense and uniform apatite was formed on the surface modified 
scaffolds after incubation for 24 h in SBF  [111]. Same type of apatite coating can also 
be formed on additive manufactured PCL scaffolds by introducing oxygen containing 
functional group on the scaffolds followed by creating nucleation site and after 
incubation for 24 h in SBF like the previous one [112]. Nucleation sites on the additive 
manufactured PCL scaffolds can also be created by impregnating scaffolds with a 
sodium silicate gel [113]. However, the dense coating on the surface of additive 
manufactured scaffolds failed to improve the osteoconductive properties of the scaffolds 
due to the flaking tendency of the apatite coating on the bars of the scaffolds. The flaking 
of the apatite coating happened due to the tensile force exerted by tissue sheets bridging 
adjacent struts of the additive manufactured scaffolds which ultimately resulted in poor 
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cell attachment, growth and mineralization [113]. In this context a thin biomimetic 
coating is desirable. Our study showed that a layer of thin composite coating of 
carbonated hydroxyapatite (CHA)-gelatin significantly improves the proliferative and 
osteoconductive properties of the additive manufactured PCL/TCP scaffolds [114]. In 
this study a CHA-gelatin composite coating with a thickness of 821 ± 53 nm was formed 
on additive manufactured PCL/TCP scaffolds through biomimetic co-precipitation 
process. Besides the apatite coating collagen mimetic peptide, GFOGER used as a 
coating on additive manufactured PCL scaffolds. GFOGER which is a synthetic triple 
helical peptide promotes osteoblastic differentiation via α2β1 integrin receptor [115]. 
GFOGER coatings passively absorbed onto the PCL scaffolds, in the absence of 
exogenous cells or growth factors, significantly increased bone volume in non-healing 
femoral defects compared to uncoated scaffolds [116] 
Additive manufactured scaffold based bone tissue engineering has only just started 
using growth factors (BMP, etc) or other biological molecules (HS, etc). BMP carriers 
play an important role in bone regeneration, for instance a non-compressible scaffold has 
been shown to promote better fusion in posterolateral spine than the clinically used 
collagen sponge [52]. Here, it should be noted that the clinically used collagen based 
carriers lack good mechanical properties. In this context, additive manufactured 
PCL/TCP scaffolds were pre-lyophilised with collagen-I to evaluate the in vivo delivery 
of rhBMP -2 in a critical sized rat cranial defect model [117]. The progression of healing 
in all modalities showed that the release of rhBMP-2 from additive manufactured 
PCL/TCP-collagen scaffolds is a clinically substantial approach to repair and regenerate 
critical size craniofacial bone defects. In another study rhBMP-2 delivered with 
immobilized heparin-gelatin modified additive manufactured poly(hydroxybutyrate-
cohydroxyvalerate) (PHBV)/Ca-P scaffolds showed significantly enhanced alkaline 
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phosphatase activity and osteogenic differentiation markers compared with the rhBMP -2 
loaded unmodified scaffolds [118]. As heparin sulphate polysaccharides improve the 
effects of growth factors on cell proliferation and differentiation, it can be hoped that 
heparin sulphate polysaccharides will intervene scaffold based bone tissue engineering 
significantly [52].  
2.7 Conclusions 
The need for bone TE scaffolds is socio-economic, and AM is showing great 
potential in this regard by providing patient specific scaffolds with controlled internal 
structure. Despite the advancements in AM scaffolds for bone TE, bone TE is still a long 
way off matching Nature’s ability to grow and repair tissues and organs. Hence, bone TE 
still has scope for enhancement. From this review it can easily be seen that scaffold 
technology is much more complex than illustrated by Figure 2.2. There are numerous 
elements or ways by which people are trying to improve the suitability of the scaffolds as 
can be seen in Figure 2.7. It can be hoped that in near future a true revolution will be 
perceived in the field of TE.  
However, the related problems in this field are multidisciplinary; we need to act in 
multidisciplinary teams. There are lots of things that must be done before the availability 
of scaffold for clinical purpose. Though there are so many obstacles, there are good signs 
in the horizon. We should keep trying to mimic properties of the natural tissues like 











Figure 2.7 Elements contributing to scaffold technology. 
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Chapter 3 
Screw Extrusion System (SES) and its Fabricated Scaffolds 
3.1 Introduction 
Screw extrusion system (SES) is a low-cost additive manufacturing technology 
enabling the fabrication of design dependent complex 3D scaffolds using various types 
of raw materials with high reproducibility [11, 12, 92, 96]. Similar to conventional 
polymer extrusion processes SES uses temperature to control the material state. The 
main features of this SES are as follows: 
• Material feeding: small volume can be fed, making it suitable for expensive 
materilas. 
• Material liquification using a controlled heating element. 
• Material movement through the barrel and nozzle due to screw assisted 
pressure. 
• Material extrusion in filament form with a controlled manner to a predefined 
path. 
• Extruded filament bonding to the previous layer to form design dependent 3D 
scaffolds.  
The parameters which would determine the quality of the fabricated scaffolds 
include the motor speed, dispensing speed, the melt temperature, the platform 
temperature, layer thickness, nozzle size and road width [92, 95]. Understanding 
different process parameters relating to the scaffolds fabrication process is important for 
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the barrel of a machine. Plastic is conveyed by the flights on the screw. Flights are the 
angled disks that are on the shaft of the screw. Typical clearance between the flights and 
the barrel are about 0.025 mm [119]. Flight depth is the distance from the tip of the flight 
and shaft of the screw. Flight depth varies between screw sections.  
Extruder screws have three sections (Figure 3.2): feed section, transition section, 
and metering section. The feed section has the greatest flight depth and is used to convey 
un-melted pellets. The transition section has a decreasing flight depth which helps to 
melt plastic and build pressure. Plastic is completely melted in this section. The metering 
section has the lowest flight depth and creates a high amount of shear which causes a 
pressure build up.  
 
Figure 3.2 Extruder screw. Adapted from [119]. 
3.2.2 Extruder body part  
Figure 3.3 shows different parts of the extruder frame. The extruder main back 
support and the front screw supports are both 27 mm from the centre of the extruder 
screw (Figure 3.4a). Thus this is a screw centric design in which the supports are built 
around the screw to allow equal loading between the front and back supports. Equal 
loading will prevent high stress generation upon the main back frame and thereby may 
have effect on reducing the upward thrust generated by the rotating screw. However, to 
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reduce the upward thrust by the rotating extruder screw, front screw supports has been 
incorporated as shown in figure 3.4b.  
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 There are two functions to the extruder front screw supports. When extrusion is 
in progress, the screw experiences an upward thrust that is handled by the frame. The 
two frontal supports takes some of the load that the rear back frame experiences, 
distributing the stress induced upon the frame. As the frame is made up of aluminium, a 
relatively soft material, distributing the stress would be beneficial in preserving the frame 
structure. Secondly, the frontal screw supports can pull the top screw support platform 
and barrel support platform to prevent the backward bending of the main back frame 
during extrusion. By doing so, the screw will not tilt and scratch the barrel when 
















Figure 3.5 Vertical barrel replacement. 
 In the extruder frame the barrel is attached vertically to the barrel support by 
screws as shown in Figure 3.5. Therefore, during cleaning the screw can be accessed 
easily just by unscrewing the six screws attaching the barrel to the barrel support, and 
barrel remains untouched which eventually prevents the misalignment that can happen if 
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3.3 Evaluation of scaffolds fabricated via in-house SES 
3.3.1 Scaffold Material 
Poly(ε-caprolactone) (PCL) (Mn: 80,000) and tri-calcium phosphate (TCP) were 
purchased from Sigma-Aldrich (Singapore) and Progentix (The Netherlands), 
respectively. PCL/TCP composite with 20 wt% of TCP was prepared by blending TCP 
powder into PCL using Brabender Mixer at 80 ºC. 
3.3.2 Scaffold Design  
 Once the material is poured into the screw extrusion system, the material 
becomes fused to a semi liquid state. The fused material is then extruded through the 
nozzle due to pressure created by screw rotation. The extruded material is then deposited 
in layers onto a flat base. The material solidifies and bonds to the preceding layer.  
Scaffolds are fabricated in layers, where a layer is built by extruding a small bead of 
material, or road, in a particular lay down pattern, such that the layer is covered with the 
adjacent filaments called roads. After a layer is completed, the height of the extrusion 
head is increased and the subsequent layers are built to construct the entire scaffold. 
Some structural features of the scaffold are shown in the Figure 3.8. RW is defined as the 
diameter of the circular cross-section of laid filament, ST is the vertical distance between 
the filament centres of adjacent layers, FG is the edge-to-edge horizontal distance 
between adjacent filaments, FD is the centre-to-centre horizontal distance between 
adjacent filaments and LG is defined as the edge-to-edge vertical distance between layers 
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It should be mentioned here that, ideally d1 should be equal to d3.  However, to 
enhance fiber adhesion between two layers and to compensate for gravitational effects on 
the circularity of the extrusion, we have reduced layer thickness approximately 8% with 
respect to the nozzle diameter. The reduction in layer thickness by 8% has chosen based 
on few experimental trials. 
 The experimental porosity value of the scaffold was measured gravimetrically as 
reported previously [121]. In this technique, porosity is defined by the following 
formula: 






where, poreV  is the part of the volume occupied by pores and polymerV  is the volume 
occupied by the polymer.  Let tsm  be the mass of the scaffold with trapped water and dsm  
the mass of the dry scaffold. The mass of water located in the pores, =poreswm dsts mm − .  
Taking into account the density of water wρ , the amount of water located in pores gives 
their volume,  









However, the volume of the scaffold taken by the polymer can be obtained by 
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bρ  was determined to be 1.2627  gm/cm3  by weighing the a block of PCL/ TCP 
composite with no pores in water and air. A balance with 0.1 mg sensitivity was used for 
the weighing purposes. 
3.3.4.2 Morphology 
 Scanning Electron Microscopy (SEM) 
 Scaffold morphology and pore size was studied using SEM.  Scaffolds were gold 
sputtered by using a JEOL fine sputter coater (JFC-1200) for 15 seconds at 10 μm.  The 
SME images were taken by Philips XL30 FEG and using the beam intensity of 15 kV 
and the gaseous secondary electron detectors at 1.3 Torr. 
3.3.4.3 Mechanical experiments 
 Compression tests were conducted on scaffolds by using an Instron 4502 
Uniaxial testing system and 5 kN load cell (Canton, MA, USA). For each group 4 
samples were tested. The scaffolds were compressed in the Z-direction at a rate of 1 
mm/min up to a strain level of approximately 80%. By strain level of 80%, it is meant 
that the scaffolds were compressed up to their 80% of the height. The stress-strain (σ-ε) 
curves were obtained to evaluate the compressive stiffness (modulus). The stiffness was 
calculated from the stress-strain curve as the slope of the initial linear portion of the 
curve, with any toe region from the initial settling of the specimen neglected. 
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3.3.5 In-vitro cell culture study 
3.3.5.1 Cell seeding on scaffolds 
Tissue culture media Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine 
serum (FBS) and penicillin-streptomycin (pen-strep) were purchased from Gibco.  
Trypsin-EDTA was purchased from Thermo Scientific Hyclone.  
Cryopreserved porcine BMSCs (passage 2), previously isolated from the iliac crest 
of pigs, were plated and expanded in T75 tissue culture flasks in DMEM supplemented 
with 10% FBS and 1% antibiotics until getting sufficient cells (not beyond passage 4). 
Medium was changed twice per week and cells were detached by trypsin-EDTA and 
passaged into fresh culture flasks at a ratio of 1:3 upon reaching confluence. Cultures 
were incubated at 37 °C in a humidified atmosphere containing 95% air and 5% CO2. 
First the scaffolds were sterilized with 70% ethanol for 30 min and then further 
sterilized under UV light for 30 minutes followed by drying in sterile condition at room 
temperature for 2 hours. Approximately 1.0×105 BMSCs were seeded onto each process 
optimized PCL/TCP scaffolds. The cell-scaffold constructs were cultured in 24-well 
tissue culture plates for up to 21 days in growth medium, and at specific time points cell-
scaffold constructs were assessed and observed for proliferation.  
3.3.5.2 Morphology of the cell-scaffolds constructs 
Confocal laser microscopy and SEM were used to assess cell viability, morphology 
and attachment in vitro. Cells were stained with 2 μg/ml of fluorescein diacetate (FDA) 
(1 mg/mL, Molecular probes) to stain the cytoplasm of the live cells with green 
fluorescence. During FDA staining, samples were incubated at 37 ºC for 15 min and 
followed by rinsing with phosphate buffer saline (PBS). Cells were then counterstained 
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with propidium iodide (PI) 5 μg/mL (1 mg/mL, Molecular probes) to stain the nucleus of 
the dead cells with red fluorescence. During PI staining the samples were kept at room 
temperature for 2 min and then rinsed with PBS. These samples were mounted for 
viewing under confocal laser microscope (IX 70, Olympus). Depth projection images 
were constructed from up to 30 horizontal image sections (12 μm each) through the 
stained cell-scaffold constructs using FV1000 Viewer (Ver.1.7a) software. After 
confocal imaging, cell-scaffolds constructs were fixed in 10% formalin overnight and 
then dehydrated through a series of graded ethanol solutions (5, 10, 20, 40, 60, 80, 90 
and 100%), each for 10 min for dehydration. Finally, the samples were dried overnight at 
room temperature. Dried cellular constructs were gold sputtered and observed under 
SEM at an accelerating voltage of 10 KV. 
3.3.5.3 AlamarBlue 
The proliferation of BMSCs was analysed with metabolic assay AlamarBlue which 
is a simple, rapid, reliable and cost-effective measurement. AlamarBlue detects cell 
viability by utilizing a noncytotoxic reduction–oxidation (redox) indicator and hence 
non-destructive [122]. First culture medium was replaced with DMEM containing 5% 
(v/v) AlamarBlue (BioSource International, Camarillo, CA) and was incubated. After 2 
hours of incubation, a microplate reader (GENios; Tecan Group, Maennedorf, 
Switzerland) was used to measure the absorbance of 100 μL samples of each well at 
wavelengths of 560 and 595 nm after shaking the well plate for 8 seconds. The data were 
normalized with 100% media and 100% AlamarBlue readings.  
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3.3.6 Results and discussion 
3.3.6.1 Porosity and dispensing speed 
 The term dispensing speed was defined by relative movement between the nozzle 
and the table. The range of dispensing speed was 6 mm/s – 12 mm/s for 0.4 mm nozzle 
diameter and for 0.5 mm nozzle diameter it was 10 mm/s – 16 mm/s while all other 
parameters were kept constant. Porosity of the scaffolds was calculated from SEM image 
measurement and also by gravimetrically by swelling the sample in water. Table 3.1 
summarised the result of theoretical porosity measured from the SEM images. The SEM 
images of the scaffolds for different dispensing speeds have been given in Figure 3.11 
and Figure 3.12 for 0.4 mm nozzle diameter and in Figure 3.13 and 3.14 for 0.5 mm 




Table 3.1 Porosity of scaffolds for different nozzle diameter. 
Dispensing speed 
(mm/s) 
d1 (mm) d2 (mm) d3 (mm) Porosity (%) 
Nozzle diameter 0.4 mm: 
6 0.59 ± 0.04 1.5 0.54 ± 0.05 65 
8 0.41 ± 0.08 1.5 0.38 ± 0.03 76 
10 0.39 ± 0.02 1.5 0.41 ± 0.02 80.5 
12 0.37 ± 0.02 1.5 0.39 ± 0.06 81.6 
Nozzle diameter 0.5 mm: 
10 0.87 ± 0.1 1.5 0.78 ± 0.15 49 
12 0.77 ± 0.09 1.5 0.63 ± 0.06 61.7 
14 0.52 ± 0.07 1.5 0.57 ± 0.05 75 
16 0.42 ± 0.04 1.5 0.41 ± 0.03 77 
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Figure 3.12 SEM images of some irregular dispensing at higher (12 mm/s) dispensing 
speed for 0.4 mm nozzle diameter. 
 




Figure 3.14 SEM images of some irregular dispensing at higher (18 mm/s) dispensing 
speed for 0.5 mm nozzle diameter. 
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The relation between theoretical and experimental porosity vs. dispensing speed for 
different nozzle diameter is illustrated in Figure 3.15. From this graph it can be seen that 
for 0.4 mm nozzle diameter the experimental porosity varies from 63.88% to 73.77%. 
The porosity of 0.4 mm nozzle diameter at dispensing speed 8 mm/s closely matches the 
porosity of 0.5 mm nozzle diameter at dispensing speed 14 mm/s. Almost 1.7 times 
higher speed is required to get the porosity from 0.4 mm nozzle diameter compared to 
the 0.5 mm nozzle diameter.  At higher dispensing speed the extruded filaments do not 
get enough time to settle down and thus the laying down of filaments becomes irregular 
due to the pulling phenomenon as illustrated in Figure 3.12 and Figure 3.14 for 0.4 mm 
and 0.5 mm nozzle diameter, respectively. As noticed from Figure 3.11 and Figure 3.13 a 
0.4 mm nozzle diameter 10 mm/s dispensing speed works well, whereas, for 0.5 mm 
nozzle diameter 16 mm/s dispensing speed works well. 
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3.3.6.2 Modulus and dispensing speed 
 The modulus of the scaffold starts decreasing with the increase of the dispensing 
speed. This is because with the increase in the dispensing speed the diameter of the 
extruded material starts decreasing due to pulling effect. Figure 3.16 shows the 
relationship between modulus and dispensing for different nozzle diameter. 
Figure 3.17 shows the relationship between compressive modulus and porosity. For 
68.89%% porosity in 0.5 mm nozzle diameter the modulus is 42.12 MPa. Whereas, for 
69.52% porosity in 0.4 mm nozzle diameter results in 7.43 MPa.  For similar porosity the 
modulus is 5.5 times higher in 0.5 mm nozzle diameter.  It may be because; the diameter 
of the filament of 0.5 mm nozzle diameter at that parameter was 0.519 mm.  However, 
the filament diameter for 0.4 mm nozzle diameter at that point was 0.413 mm.  Another 
important thing is, at the higher porosity the modulus drops in a rapid manner.  This may 
be because at higher porosity value the structure becomes too porous and collapses 
suddenly.  
From the process optimization experiments PCL/TCP scaffolds fabricated with 0.4 
mm nozzle diameter and dispensing speed of 10 mm/s have been chosen for further 
investigation. In vitro evaluation of this process optimized PCL/TCP scaffolds has been 
discussed in the next section. 
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Figure 3.16 Modulus vs. dispensing speed for different nozzle diameter. 
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3.3.6.3 In vitro cell culture results 
Figure 3.18 shows the SEM images of BMSCs cultured on PCL/TCP scaffolds at 
day 7 and day 21. At day 7, cells have attached and started to spread on PCL/TCP 
scaffolds. At day 21, cells spread well onto the PCL/TCP scaffolds and cell-sheet 










Figure 3.18 SEM images of cell-scaffold construct of PCL/TCP scaffolds at (a) day 7 
and (b) day 21. 
Figure 3.19 shows the confocal laser microscopy image of BMSCs cultured on 
PCL/TCP scaffolds at different time points. BMSCs showed a steady growth with 
respect to time on SES fabricated PCL/TCP scaffolds. 
 
 
Figure 3.19 Confocal laser microscopy of cells within the scaffolds of PCL/TCP at (a) 
day 7, (b) day 14 and (c) day 21.  
(b) (c) (a) 
50 μm 50 μm 
(a) (b) 
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AB results show a steady growth in metabolic activity of BMSCs cultured on SES 
fabricated PCL/TCP scaffolds [Figure 3.20]. All the SEM, confocal and AB results 
demonstrated that SES fabricated PCL/TCP scaffolds are biocompatible. 
Figure 3.20 BMSCs metabolism analysis using AlamarBlue. 
3.3.7 Conclusions 
The in-house SES was designed and its various process parameters were 
investigated successfully to fabricate 3D porous PCL/TCP scaffolds. The process 
optimized PCL/TCP scaffolds showed promising results in biological evaluation. The 
preliminary results not only demonstrates the feasibility of using the in-house SES to 
fabricate PCL/TCP scaffolds for bone tissue engineering but also encouraging enough to 
initiate further study to improve the mechanical and functional performance of the in-
house SES fabricated PCL/TCP scaffolds. In the next chapter the way to improve 
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Chapter 4 
Improvement of Mechanical Properties of Additive 
Manufactured PCL/TCP scaffolds 
4.1 Introduction 
Despite the high regenerative capacity of bone, large bone defects due to high 
energy trauma, bone tumour resections, congenital malfunction and severe non-union 
fractures require a bone substitute for regeneration, which is about 10% of all 
orthopaedic operations worldwide [2]. Common clinical bone substitutes include 
xenograft, allograft and autogenous cancellous bone graft from the ilium, chest or tibial 
tuberosity. Autogenous cancellous bone graft is the most common bone substitute 
because of its biological properties and lack of possibility of disease transmission or host 
rejection [3]. Nevertheless, its use is severely hampered by its short supply, temporary 
disruption of donor site bone structure and considerable donor site morbidity associated 
with the harvest [3, 4]. Therefore, the development of new synthetic bone substitute or 
scaffold that could be used instead of autogenous cancellous bone graft, has become a 
key research topic in bone tissue engineering [5-7, 123]. 
An ideal scaffold aims to mimic the mechanical and biochemical properties of the 
native tissue. Therefore, one fundamental hypothesis is to design scaffold to provide a 
biomimetic mechanical environment to withstand in vivo stress and loading [13]. 
Specifically, it was proposed that the implanted scaffold should match the stiffness and 
strength of native tissue [6, 7], which ranges from 50 to 500 MPa and 3 to 12 MPa for 
cancellous bone, respectively [15, 124]. 
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Additive manufacturing (AM) technology is a computer controlled fabrication 
process and holds the key for generic solution in automating scaffolds production 
because of its consistency and high reproducibility. It has great potential over 
conventional manual-based fabrication techniques, as the scaffolds fabricated by AM are 
design dependent, whereas the scaffolds fabricated by conventional techniques is highly 
process dependent [8]. Poly (ε-caprolactone) (PCL) is a bioresorbable and thermoplastic 
aliphatic polyester, and has been used preferably to fabricate scaffolds with AM 
technology because of its easiness in formability at relatively low temperature and good 
melt viscosity [49, 51, 125, 126]. In order to increase the mechanical properties and 
bioactivity of these PCL scaffolds, pristine ceramic particles such as hydroxyapatite 
(HA) and tricalcium phosphate (TCP) have been mixed into the PCL matrix directly [12, 
14, 127, 128]. 
Nevertheless, to date, only a slight improvement in compressive modulus and 
strength was achieved with PCL/ceramic composite scaffolds compared with those of 
PCL scaffolds. As an example, PCL/ tricalcium phosphate (TCP) composite scaffolds 
exhibited compressive modulus of 9.3 MPa and compressive strength of 3.1 MPa, while 
PCL scaffolds exhibited compressive modulus of 2.7 MPa and compressive strength of 
1.5 Mpa [14]. These PCL/TCP scaffolds are remarkably weak for cancellous bone tissue 
engineering. As reported recently in the review paper by Rezwan K. et al., the limited 
improvement on mechanical properties of polymer/ceramic composite scaffolds is 
because of the relatively low interfacial bonding between ceramic filler and polymer 
matrix [15]. Another study has also demonstrated that effective stress transfer across 
interface between polymer and ceramic filler is crucial for producing composite scaffolds 
with adequate mechanical properties [129].  
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Here, high performance additive manufactured PCL/TCP scaffolds have been 
developed for bone tissue engineering by using different binders. In part I and part II of 
this chapter silanized PCL/TCP and POSS modified PCL/TCP composite has been 
described in details, respectively. To synthesize silanized PCL/TCP composite TCP was 
modified using 3-glycidoxypropyl trimethoxysilane (GPTMS) to enhance the interfacial 
bonding between TCP and PCL matrix. To ensure the formation of covalent bonding 
between TCP(Si) and PCL, the dried PCL/TCP(Si) composites was annealed at 120 ºC 
for 2 hr. To synthesize POSS modified PCL/TCP composite PCL, TCP and POSS were 
melt compounded at 120 ºC for 20 min. The dried POSS modified PCL/TCP 
(PCL/TCP(POSS)) composite was further modified through annealing at 180 ºC for 2 hr. 
After synthesizing both of the composites, scaffolds were fabricated using an in-house 
screw extrusion system (SES). The fabricated scaffolds were evaluated in terms of 
physical, mechanical and biological characterizations. We hypothesized that such 
developed scaffolds would provide suitable mechanical properties for using in bone 
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4.2 Part I – Silanized PCL/TCP(Si): composite synthesis, scaffolds 
fabrication and characterization  
4.2.1 Materials and methods 
4.2.1.1 Materials 
Poly(ε-caprolactone) (PCL) (Mn: 80,000) and 3-glycidoxypropyl trimethoxysilane 
(GPTMS) were purchased from Sigma-Aldrich, Singapore. Tri-calcium phosphate (TCP) 
was purchased from Progentix, The Netherlands.   
4.2.1.2 Synthesis of PCL/TCP(Si) 
Surface activation of TCP was carried out by stirring TCP in 2% phosphoric acid 
(1:2 w/w) at room temperature for 2 hr followed by sonicating for 5 minutes [130]. The 
surface activated TCP was washed first with distilled water for 3 times to remove free 
phosphoric acid and then with acetone for 3 times to remove water, and suspended in 
actone. GPTMS was then added into TCP acetone suspension and refluxed at 75 ºC for 
24 hours.  GPTMS modified TCP (TCP(Si)) was collected through filtration followed by 
thorough wash with acetone to remove free GPTMS. The TCP(Si) was incorporated into 
PCL through homogenizing PCL/TCP(Si) acetone solution at 8000 rpm for 15 minutes. 
After evaporating off acetone, the homogenized composite was vacuum dried at 50 ºC 
for 1 week. Finally, PCL/TCP(Si) composite was melt compounded at 120 ºC for 20 
minutes and annealed at 120 ºC for 2 hours. 
4.2.1.3 Fabrication of the PCL/TCP(Si) scaffolds by SES  
Additive manufactured PCL/TCP(Si) composite scaffolds were fabricated using an 
in-house screw extrusion system (SES) with screw rotational speed of 25 rpm and nozzle 
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diameter of 0.4 mm at processing temperature of 85 ºC. The center to center distance of 
the scaffold struts was set to 1.5 mm. Each layer of the scaffolds was fabricated with the 
designed pattern of 0º/60º/120º orientation. The size of the scaffolds used for mechanical 
test was 5 mm × 5 mm × 8 mm and that for cell culture was 5 mm × 5 mm × 3.5 mm. 
PCL/TCP scaffolds were also fabricated as control. 
4.2.1.4 Characterization 
The surface chemical structure of TCP(Si) was characterized by XPS (Thetaprobe 
from Thermo Scientific), using a source of monochromated Al Kα (1486.6 eV) along 
with flood gun for surface charge compensation (energy 2 eV, emission current 100 
mA). Detector was set at standard lens mode CAE (contact analyzer energy) and passed 
energy for survey spectra is 200 eV and 40 eV for high resolution spectra. Data analysis 
was done using the Avantage software. FTIR spectra of TCP and TCP(Si) minced into 
the KBr pallet were recorded on a Bio-Rad 165 FT-IR spectrophotometer; 64 scans were 
signal-averaged with a resolution of 2 cm-1 at room temperature. Differential scanning 
calorimetry (DSC) measurements were performed using a TA Instruments 2920 
differential scanning calorimeter equipped with an auto-cooling accessory and calibrated 
using indium. The following protocol was used for each sample: heating from room 
temperature to 120 °C at 20 °C min-1, holding at 120 °C for 2 minutes, cooling from 120 
to -30 °C at 5 °C min-1, and finally reheating from -30 to 170 °C at 5 °C min-1. Data were 
collected during the second heating run. The degree of crystallinity was calculated 
according to the following equation: 
Crystallinity (%) = (∆Hm/ 0.8/∆Hmº) × 100%; where Hm is the melting enthalpy (J/g) 
of composite; 0.8 is the weight percentrage of PCL in the composite and ∆Hmº (139.5 
J/g)  is the melting enthalpy of 100% crystalline PCL [131]. 
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 Compressive modulus and compressive strength of the scaffolds were measured 
using an Instron 4502 uniaxial testing system with 5 kN load cell at a rate of 1 
mm/minute. All scaffolds had the size of 5 mm × 5 mm × 8 mm and 0º/60º/120º lay 
down patterns. Ten scaffolds were tested from each group and measurements were 
reported as mean ± standard deviation. 
The surface morphology of the scaffolds was studied with a Quanta 200F field 
emission scanning electron microscope (FESEM) at a beam intensity of 10 kV after gold 
sputtering using a JFC-1200 fine sputter coater. 
4.2.1.5 Cell seeding on scaffolds  
BMSCs (1.8×105 cells) were added onto each of the PCL/TCP and PCL/TCP(Si) 
scaffold according to the protocol described in the in vitro cell culture study section of 
chapter 3. The cell-scaffold constructs were cultured up to 10 days in growth medium, 
and at specific time points cell-scaffold constructs were assessed and observed for 
proliferation. For osteogenic induction, after 10 days of culture in growth medium, an 
osteogenic cocktail of dexamethasome (10 nM), ascorbic acid (50 μM  ) and β-
glycerolphosphate (10 mM) (Sigma) was added. The cell-scaffold constructs were 
cultured further for 28 days post induction and samples were assessed at definite time 
points for gene and protein expressions. 
4.2.1.6 Morphology of the cell-scaffold constructs  
SEM and confocal laser microscopy were used to assess cell morphology, viability 
and attachment in vitro according to the protocol described in the in vitro cell culture 
study section of chapter 3. 
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4.2.1.7 PicoGreen® Assay  
Proliferation of BMSCs in cultured cell-scaffold constructs were studied using 
PicoGreen® assay as per manufacturer’s protocol (Molecular Probes, PicoGreen dsDNA 
Quantitation kit). Total DNA from cells in the constructs were extracted via freeze-thaw 
cycles. DNA amount in the cell lysate were then assayed by mixing with DNA binding 
PicoGreen® dye followed by spectrophotometer quantisation. 
4.2.1.8 Gene Expression (Real-time RT-PCR)  
At specified time points, the cell-scaffold constructs were lysed with Trizol 
(Invitrogen) and thoroughly vortexed. The samples in Trizol were stored at -80 °C until 
RNA isolation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen) with 
Rnase-Free DNase (Qiagen) according to the manufacturer’s protocol.  
Reverse transcription was performed with the QuantiTect Reverse Transcriptase kit 
(Qiagen) to make the required cDNA. Quantitative PCR was performed for the 
quantification of gene expressions using the primers listed in Table 4.1 and QuantiTect 
SYBR Green PCR kit (Qiagen) Mx3000P Real-Time PCR System (Stratagene). Target 
genes were normalized against the GAPDH expression.  
Table 4.1. Forward primers and reverse primers used in RT-PCR. 
Gene ID Forward Primer Reverse Primer 
GAPDH GCTTTGCCCCGCGATCTAATGTTC GCCAAATCCGTTCACTCCGACCTT 
CBFA1 GAGGAACCGTTTCAGCTTACTG CGTTAACCAATGGCA CGA G 
COL1 CCAAGAGGAGGGCCAAGAAGAAGG GGGGCAGACGGGGCAGCACTC 
OCN TCAACCCCGACT GCGACGAG TTGGAGCAGCTG GGATGATGG 
 
4.2.1.9 Western Blot Study (WB)  
Protein extracts were harvested from the cell-scaffold constructs with ice-cold 
radioimmunoprecipitation assay (RIPA) buffer (Thermo Scientific). Protein lysates were 
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purified and concentrated using NanoSep columns (Pall 3K). Total protein quantity was 
quantified using microBCA assay (Pierce) as per manufacture’s protocol. Proteins were 
denatured at 90 °C for 5 minutes, resolved by 10% SDS-PAGE (polyacrylamide gel 
electrophoresis) and transferred to nitrocellulose membranes (Bio-Rad). After blocking 
with 1% non-fat milk in tris-buffered saline (TBS) for 1 hrour, the membranes were then 
incubated for 1 hour with primary antibodies: polyclonal rabbit-anti-human beta-actin 
(Delta Biolabs), osteonectin (ON), osteocalcin (OCN) (Santa Cruz) or osteopontin 
(OPN) (Abcam). The primary antibodies were diluted from 1:500 to 1:2000 in TBS with 
0.1% Tween (TBST). After three washes with TBST, membranes were next incubated 
with rabbit anti-goat HRP-conjugated secondary IgG (Zymed) at 1:15,000 for 1 hour, 
followed by another three washes with TBST. Immunoreactive bands were visualised 
and detected using the SuperSignal Chemiluminescent reagent (Pierce) on the VersaDoc 
Imaging Systems (Bio-Rad). The intensities of the bands were quantitatively analyzed 
using densitometry (Quantity-One, Bio-Rad). Target proteins were normalized against 
the β-actin expression.  
4.2.1.10 Statistical Analysis  
All the data presented are expressed as mean ± standard deviation.  An unpaired 
student’s t-test was used to test the significance level of the data. Differences were 
considered statistically significant at p<0.05. 
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4.2.2 Results and Discussions 
4.2.2.1 PCL/TCP(Si) composite preparation and scaffolds fabrication 
 In order to prepare additive manufactured PCL/TCP scaffolds with adequate 
mechanical property for cancellous bone tissue engineering, the interfacial bonding 
between PCL and TCP was enhanced by modifying TCP using GPTMS as a coupling 
agent. The main idea is that the epoxide group from GPTMS attached to TCP could react 
with the end groups of PCL chain (-OH and -COOH) to form covalent bond during melt-
compounding and the followed annealing. Figure 4.1 shows the schematic diagram of 
TCP modification as well as the covalent bond formation between TCP(Si) and PCL. 
First, hydroxyl group was introduced onto TCP by stirring its suspension in a diluted 
phosphoric acid (2 wt%) for 2 hours as reported previously [130]. Then, GPTMS was 
covalently bonded onto the surface of TCP via condensation reaction with the introduced 
hydroxyl group on TCP. The successful modification of TCP was verified by X-ray 
photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FTIR). 
As shown in Figure 4.2, while only calcium, phosphorous and oxygen are detected on the 
surface of non-treated TCP using XPS, additional silicon peak (Si(2p): 99.8 eV; and 
Si(2s): 149.7 eV) from GPTMS is observed in the XPS spectrum of TCP(Si), confirming 
the presence of GPTMS on TCP. In the FTIR spectrum of TCP(Si) (Figure 4.3b), 
observation of additional characteristic epoxide band at 873 cm-1 in comparison to that of 
TCP also confirms the presence of GPTMS on TCP(Si). TCP(Si) with varying 
concentration of GPTMS was synthesized to study the influence of GPTMS content on 
the mechanical property of PCL/TCP(Si) scaffolds. 
The synthesized TCP(Si) was suspended in acetone and mixed into PCL acetone 
solution by homogenizing at high speed. After evaporating off acetone using rotary 
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evaporator, the PCL/TCP(Si) composite was melt-compounded at 120 °C for 20 minutes 
followed by annealing at 120 °C for 2 hours to facilitate the formation of covalent bond 
between epoxide from TCP(Si) and –OH or –COOH from PCL. Similar chemical 
reaction has been reported previously [132, 133]. 
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Figure 4.2 XPS spectra of (a) TCP and (b) TCP(Si). 
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mechanical properties, it has been chosen for in vitro evaluation, and denoted as 
PCL/TCP(Si). 
Figure 4.5 Compressive modulus (a) and compressive strength (b) of PCL/TCP and 
PCL/TCP(Si) scaffolds with various content of GPTMS referred to TCP. 
PCL is a semi-crystalline polymer, and the crystallinity degree of PCL in PCL/TCP 
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scanning calorimeter (DSC) and the results were listed in Table 4.2. It was found that the 
crystallinity degree of PCL in PCL/TCP(Si) with various GPTMS content is much higher 
than that in PCL/TCP. This may be due to the enhanced interfacial bonding between 
TCP(Si) and PCL, leading to higher nucleating efficiency of TCP(Si) for the 
crystallization of PCL. This increase in the crystallinity degree is correlated with the 
increase in compressive modulus and strength [134]. However, the melting temperature 
seemed to be independent of the introduction of GPTMS. 
Table 4.2 Thermal property of PCL/TCP(Si) composites determined by DSC 
wt% of GPTMS to TCP Melting temperature (ºC) Crystallinity (%) 
0 55.3 39.9 
5 55.0 47.2 
10 55.1 47.7 
15 54.8 46.4 
 
 
Figure 4.6 SEM images of (a) PCL/TCP and (b) PCL/TCP(Si) scaffolds. 
 The surface morphology of PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-
CHA-gelatin scaffolds was characterized by using SEM. As shown in Figure 4.6 both 
PCL/TCP and PCL/TCP(Si) scaffolds exhibit smooth surface morphology. 
4.2.2.2 In vitro cells response 
The cell-scaffold interaction is crucial for tissue engineering, and an ideal scaffold 
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self-renewal capability, multilineage differentiation potential and similar prospect as 
embryonic stem cells, but they are less related with ethical issues and tumorigenesis risks 
[135]. Therefore, BMSCs have been widely employed for in vitro study of bone 
formation and evaluating the biocompatibility of a newly developed material for bone 
tissue engineering [135-137]. In this study, the biocompability of the developed 
PCL/TCP(Si) scaffolds are evaluated by observing BMSCs morphology, proliferation, 














Figure 4.8 Confocal laser microscopy with depth projection images reconstructed from 
multiple horizontal images, showing 3D distribution of cells within the scaffolds of 
PCL/TCP and PCL/TCP(Si) scaffolds. 
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(a) (b) 
   Day 3                         Day 7                        Day 10 








   
   
   






  Chapter 4. 
69 
Figure 4.7 shows the SEM images of BMSCs cultured on PCL/TCP and 
PCL/TCP(Si) scaffolds at day 7. For both PCL/TCP and PCL/TCP(Si) scaffolds the cells 
appeared to spread almost in the same manner. 
Figure 4.8 shows the confocal laser microscopy image of BMSCs cultured on 
PCL/TCP and PCL/TCP(Si) scaffolds at different culture time. With predominantly in 
round shape, at day 10, for both of the groups cells have grown almost in similar manner 
in all the time points. 
 
Figure 4.9 PicoGreen® DNA quantification results of BMSCs cultured on PCL/TCP and 
PCL/TCP(Si) scaffolds.  
Figure 4.9 shows the proliferation of BMSCs in the cell-scaffold constructs studied 
by PicoGreen® assay. At all the time points, PCL/TCP(Si) scaffolds exhibited almost 
similar amount of DNA content like PCL/TCP scaffolds. The differentiation of BMSCs 
in the cell-scaffold constructs was studied by RT-PCR analysis. The quantitative RT-
PCR analysis (Figure 4.10) revealed that PCL/TCP(Si) exhibited higher amount of Cbfa1 
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considered as an important transcription factor for the commitment of multipotent 
mesenchymal cells into the osteoblastic lineage by triggering the gene expression of 
bone matrix proteins [138, 139]. On the other hand, (OCN) which is one of the terminal 
differentiation markers and collagen I (Col1) which relates to further BMSCs 
differentiation to osteoblast, both showed slightly basal expression at day 17 and 24.  
To analyze the extracts of protein formed on cell-scaffold constructs western 
blotting was carried out after BMSCs were cultured for 31 days. As can be seen in Figure 
4.11 osteonectin (ON) which is an important non-collagen calcium binding glycoprotein 
and osteopontin (OPN) which is another mineral-binding protein found in bone 
extracellular matrix are almost in the same level for PCL/TCP and PCL/TCP(Si). 
Whereas, bone-specific glycoprotein OCN is 1.2 times higher amount for PCL/TCP(Si).  
All these in vitro studies demonstrated that PCL/TCP(Si) scaffolds possess the same 
level of biocompatibility like PCL/TCP scaffolds, indicating GPTMS modification on 
TCP does not lead to any detrimental effect on BMSCs activity as also reported 
previously on the biocompatibility of silane treated surface [138, 140, 141]. 
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Figure 4.10 mRNA expression of Cbfa1, Collagen I (Col1) and Osteocalcin (OCN) of 
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4.3 Part II – POSS modified PCL/TCP(Si): composite synthesis, scaffolds 
fabrication and characterization  
4.3.1 Materials and methods 
4.3.1.1 Materials 
Tri-silanollsobutyl POSS was purchaged from Hybrid Plastics, USA. PCL and TCP 
were purchased  from  Sigma-Aldrich, Singapore and Progentix, The Netherlands, 
respectively as mentioned in part I. 
4.3.1.2 Synthesis of PCL/TCP(POSS) 
PCL, TCP and POSS were melt compounded at 120 ºC for 20 min with 2, 4, 6, 8 
and 10% of POSS composition referred to PCL/TCP composite. To ensure successful 
bonding between PCL, TCP and POSS, the dried POSS modified PCL/TCP 
(PCL/TCP(POSS)) composite was further modified through annealing at 180 ºC for 2 hr. 
After synthesizing the composites, scaffolds were fabricated using an in-house SES. 
4.3.1.3 Fabrication of the PCL/TCP(POSS) scaffolds by SES  
The scaffolds were fabricated as described in the part I of this chapter. 
4.3.1.4 Characterization 
Compressive modulus and compressive strength of the scaffolds were measured 
using an Instron 4502 uniaxial testing system as described in the part I of this chapter. 
Here, compression testing was done in both dry and simulated physiological test. 
Scaffolds were immersed in phosphate buffer solution (PBS) for 24 hr at 37 ºC before 
conducting compression testing in physiological condition. 
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The surface morphology and chemical structure of the scaffolds were characterized 
by FESEM and XPS as described in the part I of this chapter. 
The processibility of PCL/TCP(POSS) composite was evaluated by a bench top 
capillary rheometer, Rosand 2000 (Malvern, USA) using a 1 mm diameter die. The 
composite was processed at 85 ºC and processibility was evaluated in terms of shear 
viscosity.  
4.3.1.5 Cell seeding on scaffolds  
Rat BMSCs (1.8×105 cells) were added onto each of the PCL/TCP and 
PCL/TCP(POSS) scaffold according to the protocol described in the in vitro cell culture 
study section of chapter 3. The growth media of the cell-scaffold constructs was 
supplemented with an osteogenic cocktail of dexamethasome (10 nM), ascorbic acid (50 
μM) and β-glycerolphosphate (10 mM) (Sigma) throughout the experiment. 
4.3.1.6 Morphology of the cell-scaffold constructs  
SEM and confocal laser microscopy were used to assess cell morphology, viability 
and attachment in vitro according to the protocol described in the in vitro cell culture 
study section of chapter 3. 
4.3.1.7 PicoGreen® Assay  
Proliferation of BMSCs in cultured cell-scaffold constructs were studied using 
PicoGreen® assay as described in part I of this chapter. 
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4.3.1.8 Alkaline phosphate activity (ALP)  
Osteogenic differentiation of the cells was measured using ALP biomarker. At pre-
determined time-points, cell-scaffold constructs were cut into smaller pieces and 
incubated in radio-immuno precipitation assay (RIPA) buffer for 10 min at 4 ºC to allow 
lysis of cells. The constructs were then briefly vortexed and the lysate re-located into 1.5 
mL Eppendorf tubes. The lysates were centrifuged at 13.2 K rpm for 10 min at 4 ºC to 
separate the supernatant from cellular and tissue debris. Amount of total protein in each 
lysate was quantified using BCA Protein Assay kit (Thermo Scientific, #23225) 
according to manufacturer's protocol. Equal amount of total protein was loaded for every 
sample into a 96 multi-well plate. The protein solution was then incubated with a 
solution of pNPP Substrate for Alkaline Phosphatase (Invitrogen, #00-2212) for 60 min 
at 37 ºC. Absorbance of the resulting solution was read at 405 nm using a Victor3 1420 
Multi label Counter (Perkin Elmer). 
4.3.1.9 Statistical Analysis  
All the data presented are expressed as mean ± standard deviation.  An unpaired 
student’s t-test was used to test the significance level of the data. Differences were 
considered statistically significant at p<0.05. 
4.3.2 Results and Discussions 
4.3.2.1 PCL/TCP(POSS) composite preparation and scaffolds fabrication 
 As a continuation effort to prepare additive manufactured PCL/TCP scaffolds with 
adequate mechanical property for bone tissue engineering, POSS has been used as a 
coupling agent to improve the interfacial bonding between PCL and TCP. POSS is a 
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hybrid (organic–inorganic) nanostructured macromere and has been used extensively in 
the field of polymeric nanocomposites [142-144]. The incorporation of POSS derivatives 
into polymeric materials can lead to different improvements in polymer properties 
including mechanical properties and processibility [145, 146]. In recent years it has been 
shown that POSS are biocompatible and have a great potential in the field of tissue 
engineering [147, 148]. In this context, POSS has been used to modify PCL/TCP 
composite. The hydroxyl groups of POSS are capable of reacting with the carboxyl end 
groups of PCL, thus covalently binding the nanostructured moiety to the polymer [149]. 
To ensure this covalent bonding PCL/TCP(POSS) composite was annealed at 180 ºC. 
Similar reaction has been mentioned elsewhere [145].  
Additive manufactured PCL/TCP(POSS) scaffolds were fabricated from the 
synthesized PCL/TCP(POSS) composite using an in-house SES with pore size of 750-
950 μm and overall porosity of 65%. PCL/TCP scaffolds with the same dimension were 
also fabricated as control. The compressive modulus and strength of PCL/TCP(POSS) 
scaffolds with varying content of POSS were measured by compression testing, and 
compared with those of PCL/TCP scaffold both in dry and simulated physiological state. 
As shown in Figure 4.12, both compressive modulus and strength of PCL/TCP(POSS) 
scaffolds are significantly higher than those of PCL/TCP scaffold, and PCL/TCP(POSS) 
scaffold with 4 wt% of POSS referred to PCL/TCP composite exhibits the maxima 
compressive modulus of 93.8 MPa and compressive strength of 6.0 MPa, which are 6.9 
and 3.5 times of those of PCL/TCP scaffolds, respectively. The compressive modulus of 
PCL/TCP decreased by 15% in simulated physiological state compared to dry state, 
whereas except 10 wt% POSS modified scaffolds all other POSS modified scaffolds 
reduced by less than 10%. This result indicates the capability of POSS modified 
scaffolds to retain mechanical properties in simulated physiological condition. Among all 
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the POSS modified groups 4 wt% POSS modified PCL/TCP scaffolds showed best 
mechanical properties, hence the rest of the characterizations and in vitro evaluation was 














Figure 4.12 Compressive modulus (a) and (b) compressive strength of PCL/TCP and 
PCL/TCP(POSS) scaffolds with various content of POSS referred to PCL/TCP 
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The surface morphology of PCL/TCP and PCL/TCP(POSS) scaffolds was 
characterized by using SEM. As shown in Figure 4.13 PCL/TCP scaffolds exhibit 
smooth surface morphology, whereas PCL/TCP(POSS) showed exposed TCP. During 
polymer ceramic blending, generally ceramic particles are covered by polymer during 
mixing, and hence the bioactivity of the ceramic particles reduced [150]. In this respect 
the findings of exposed TCP on the scaffolds surface is quite interesting. To confirm the 
presence of exposed TCP, XPS was carried out. As shown in Figure 4.14, while only 
carbon and oxygen are detected on the surface of PCL/TCP scaffolds, additional calcium 
and phosphorous peaks are observed in the XPS spectrum of PCL/TCP(POSS) scaffolds, 
confirming the presence of exposed TCP on the surface of the scaffolds.  
 As can be seen from Figure 4.15 shear viscosity reduces with the increase of POSS 
addition. This signifies that POSS can also be used to improve the processibility of 
PCL/TCP composite. Similar phenomenon has been noticed while POSS were blended 






Figure 4.13 SEM images of (a) PCL/TCP and (b) PCL/TCP(POSS) scaffolds. 
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Figure 4.14 XPS spectra of (a) PCL/TCP and (b) PCL/TCP(POSS) scaffolds. 
 
Figure 4.15 Shear viscosity vs. shear rate of PCL, PCL/TCP and PCL/TCP(POSS) with 
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4.3.2.2 In vitro cells response 
In this study, the biocompability of the developed PCL/TCP(POSS) scaffolds are 
evaluated by observing rat BMSCs morphology, proliferation, and ALP expression. 
Figure 4.16 shows the SEM images of BMSCs cultured on PCL/TCP and 
PCL/TCP(POSS) scaffolds at day 14 and 21. At day 21, cells on PCL/TCP appeared to 
spread in a limited manner compared to PCL/TCP(POSS) scaffolds. Moreover, cells on 
PCL/TCP(POSS) scaffolds showed apparently better contact with surface compared to 
PCL/TCP scaffolds. 
Figure 4.17 shows the confocal laser microscopy image of BMSCs cultured on 
PCL/TCP and PCL/TCP(POSS) scaffolds at day 14 and 21. At day 21, PCL/TCP(POSS) 
scaffolds showed uniform distribution of cells compared to PCL/TCP scaffolds, and thus 
the confocal imaging result is in line with the SEM result.  
Figure 4.18 shows the proliferation of BMSCs in the cell-scaffold constructs studied 
by PicoGreen® assay. At day 14, PCL/TCP(POSS) scaffolds exhibited around 1.3 times 
higher amount of DNA content compared to PCL/TCP scaffolds. However, no 
statistically significant result has been noticed. 
To measure the osteogenic differentiation of BMSCs ALP expression has been 
measured. It has been used as measuring ALP expression is straight forward, reliable and 
less expensive. As can be seen from Figure 4.19 PCL/TCP(POSS) scaffolds exhibited 
greater amount of ALP expression compared to PCL/TCP scaffolds. At day 21 and day 
28, PCL/TCP(POSS) scaffolds exhibited almost 4.4 and 2.1 times higher amount of ALP 
expression compared to PCL/TCP scaffolds. The cells on PCL/TCP(POSS) scaffolds get 
contact with the exposed TCP, and therefore, they are more line to the osteogenic lineage 
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compared to the cells on PCL/TCP scaffolds. Previous study also showed that calcium 








Figure 4.16 SEM images of cell-scaffold construct of PCL/TCP and PCL/TCP(POSS) 









Figure 4.17 Confocal laser microscopy with depth projection images reconstructed from 
multiple horizontal images shows 3D distribution of cells within the scaffolds of 
PCL/TCP and PCL/TCP(POSS). 
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Figure 4.18 PicoGreen® DNA quantification results of rat BMSCs cultured on PCL/TCP 
and PCL/TCP(POSS) scaffolds (*p<0.05).  
 
Figure 4.19 Alkaline phosphate expression normalized to protein content of rat BMSC 
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All these in vitro studies demonstrated that PCL/TCP(POSS) scaffolds are suitable 
for bone tissue engineering, as we can also found from previous studies [147, 148]. 
Moreover, our study suggests that PCL/TCP(POSS) scaffolds may be more beneficial 
due to the exposed TCP particles on the surface of the scaffolds. 
4.3.3 Conclusions 
In this study POSS modified PCL/TCP scaffolds with enhanced mechanical 
properties have been successfully prepared. PCL/TCP(POSS) scaffolds showed 6.9 times 
higher compressive modulus and 3.5 times higher compressive strength than those of 
PCL/TCP scaffolds and eventually falls within range of the mechanical properties 
(stiffness 50 to 500 MPa and strength 3 to 12 MPa) of cancellous bone. This study also 
suggests that POSS can be used not only to improve the mechanical properties but also 
the processibility of PCL/TCP scaffolds. Due to the change of viscoelastic properties of 
the POSS modified scaffolds TCP has been exposed to the surface. This exposed TCP 
may improve the biocompatibility of the POSS modified PCL/TCP scaffolds. This claim 
can be supported from the findings of SEM, confocal images and ALP activity of in vitro 
study. 
In this chapter two different types of coupling agent namely, silane and POSS have 
been used successfully to improve the mechanical properties of the PCL/TCP scaffolds. 
Both of the silane and POSS modified PCL/TCP scaffolds have significantly improved 
mechanical properties compared to control PCL/TCP scaffolds, and are suitable to be 
used for cancellous bone TE applications. However, in terms of biocompatibility and 
mechanical properties POSS modified scaffolds showed better performance compared to 
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silane modified scaffolds. Eventually this study extends the potential of melt extrusion 
based additive manufactured composite scaffolds for bone tissue engineering.  
However, a scaffold should not only have adequate mechanical properties but also 
have functional properties like improved biocompatibility and cells entrapment system. 
In the subsequent chapters, silane and POSS modified PCL/TCP scaffolds will be used 
for further modification to improve the biocompatibility and cells entrapment efficiency 
of the scaffolds, respectively. To improve the proliferative and osteoconductive 
properties of the scaffolds biomimetic composite coating has been developed on 










  Chapter 5. 
85 
Chapter 5 
Development of Biomimetic Composite Coating on 
PCL/TCP(Si) scaffolds 
5.1 Introduction 
Polymer/ceramic composite scaffolds are preferable candidates for bone tissue 
engineering because they integrate the favourable properties of both the polymer and 
ceramic, and hence enhance mechanical properties and biocompatibility [12, 14, 128]. 
However, blending ceramic with polymer directly may lead to masking of the ceramic 
particles with polymer [150]. This limits exposure of ceramics on the scaffold surface 
and hinders the direct contact of cells to the bioactive ceramics particles, and thus 
diminishes the osteoconductive property offered by the ceramic particles. Therefore, in 
order to improve the osteoconductive property of the polymer/ceramic composite 
scaffolds, a layer of ceramic coating on the scaffold’s surface is considered as an 
efficient approach. It should be noted that ideal surface coating can provide desirable 
biological properties to the bulk implant, whilst retains the structural properties of the 
scaffolds.   
Among various coating approaches, the biomimetic approach acts in a more 
efficient and similar way to the natural system [153]. Kokubo et al. first reported the use 
of simulated body fluid (SBF) for biomimetic growth of apatite coatings on bioactive 
CaO-SiO2 glass by mimicking the natural biomineralization process [154]. However, this 
conventional biomimetic process exhibits some limitations, notably the time consuming 
nature of the process which may take several weeks [155, 156]. Though the process time 
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could be shortened by using concentrated SBF, it still requires a constant pH and 
replenishing the concentrated SBF frequently to maintain supersaturation for apatite 
crystal growth [157]. Therefore, an alternative, simpler and more efficient approach for 
biomimetic coating is required.  
Previous study on AM scaffolds coated with apatite did not find any promising 
result due to flaking of the thick apatite layer on the scaffolds [113]. To reduce the 
flaking tendency composite coating may be desirable, as a recent study proved that 
collagen can promote both the cohesive and adhesive properties of apatite coating on 
titanium with a significantly higher coating retention for the apatite-collagen composite 
coating compared to apatite coating [158]. However, relatively little work has been 
reported on apatite-collagen composite coating on polymer related scaffolds [159]. More 
specifically there is no study of such composite coating on AM scaffolds. 
In comparison to collagen, collagen-based gelatin has a higher degree of biological 
functional groups and, as gelatin is denatured, it overcomes the possible concerns of 
immunogenicity associated with collagen. Moreover, its cost efficiency can facilitate its 
selectivity over collagen. Previous studies have reported the use of hydroxyapatite (HA)-
gelatin composite as a scaffold for bone tissue engineering [160-162]. It was found that 
stimulation of osteoblast responses were significantly higher on co-precipitated HA-
gelatin scaffolds than on pure gelatin or conventional HA-gelatin scaffolds prepared by 
directly mixing the gelatin with HA [161]. However, biological apatites are always 
carbonated from a compositional point of view. Carbonated hydroxyapatite (CHA) 
implants exhibit higher osteoconductive properties and earlier bioresorption compared to 
HA samples [163]. Therefore, we hypothesize that the combination of CHA and gelatin 
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as a composite coating through biomimetic co-precipitation has the potential to be an 
effective biomimetic coating for bone tissue engineering.     
The objective of the present study is to develop a facile but efficient approach to 
provide a biomimetic composite coating on AM scaffolds for bone TE. CHA-gelatin 
composite coating was formed on previously developed PCL/TCP(Si) scaffolds through 
biomimetic co-precipitation. CHA coated scaffolds were also prepared to understand the 
influence of gelatin incorporation on cell proliferation and differentiation activity. The 
scaffolds were evaluated for surface morphology, composition and compressive 
modulus. The biological capabilities of these scaffolds were also evaluated by culturing 
porcine bone marrow stromal cells (BMSCs) on the scaffolds.  
5.2 Materials and methods 
5.2.1 Materials 
Poly(ε-caprolactone) (PCL) (Mn: 80,000), gelatin (type A, from porcine skin), 
calcium chloride (CaCl2), phosphoric acid (H3PO4, 85% solution in water), sodium 
carbonate (Na2CO3), acetic acid (CH3COOH), sodium hydroxide (NaOH), and potassium 
hydrophosphate (K2HPO4) were purchased from Sigma-Aldrich (Singapore). Tri-calcium 
phosphate (TCP) was obtained from Progentix (The Netherlands). 
5.2.2 Fabrication of PCL/TCP(Si) scaffolds by SES 
PCL/TCP(Si) scaffolds were developed and fabricated according to the process 
described in the materials and methods of chapter 4. 
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5.2.3 Surface coating on PCL/TCP scaffolds 
PCL/TCP(Si) scaffolds were first treated in 10 ml 5 M NaOH at room temperature 
for 12 hours followed by thorough washing with de-ionized water to remove the free 
NaOH. The NaOH treated scaffolds were then dipped alternately into calcium chloride 
solution and potassium hydrophosphate solution to obtain CaHPO4 coating as a 
nucleation site for the next CHA coating or CHA-gelatin composite coating [111]. In 
brief, the NaOH treated scaffolds were dipped in 20 mL 0.2 M CaCl2 aqueous solutions 
for 10 minutes and then dipped in de-ionized water for 5 seconds followed by air drying 
for 3 minutes. The sample was subsequently dipped in 20 mL 0.2 M K2HPO4 aqueous 
solutions for 10 minutes and then dipped in de-ionized water for 5 seconds followed by 
air drying for 3 minutes. The whole process was repeated three times. 
The CaHPO4 coated scaffolds were immersed into 20 mL 0.1 M CH3COOH, and 
then 10 ml 0.1 M CaCl2 and 6 ml 0.1 M H3PO4 (Ca/P = 1.66) were dropped slowly 
through separate syringe pumps under stirring. The pumps were adjusted to keep the 
ratio of Ca/P at 1.66. After further stirring for 30 min, 18 ml 0.1 M Na2CO3 with the 
molar ratio of CO32- / PO43- = 3 was dropped gradually. The mixture was stirred for 
another 30 min and then, the pH of the mixture was adjusted to 9 using 0.1 M NaOH. 
The CHA coated PCL/TCP(Si) scaffolds (PCL/TCP(Si)-CHA) were collected after aging 
the solution for 3 hr. Finally, the scaffolds were washed with de-ionized water 
thoroughly and freeze dried.  
For preparing CHA-gelatin composite coated PCL/TCP(Si) scaffolds 
(PCL/TCP(Si)-CHA-gelatin), first 40 mg gelatin was dissolved into 20 ml de-ionized 
water at 37 ºC to get gelatin solution (2 mg/mL). Then CaHPO4 coated scaffolds were 
dipped into the above gelatin solution for 0.5 hr followed by washing with de-ionized 
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water to remove free gelatin. The gelatin coated scaffolds were then immersed into 20 ml 
0.1 M CH3COOH solution dissolved with 40 mg gelatin. Finally CHA-gelatin composite 
was coated onto the gelatin treated PCL/TCP(Si) scaffolds by adding CaCl2 and H3PO4 
following the same process as that of CHA coating.  
5.2.4 Scaffolds characterizations 
The surface morphology of scaffolds was observed with a field emission scanning 
electron microscope (SEM) (Philips XL30 FEG) according to the methods described in 
the materials and methods of chapter 4. The thickness of CHA coating and CHA-gelatin 
composite coating were measured from the cross-section SEM image of filament in 
coated scaffolds. Attenuated total refraction Fourier transform infrared spectroscopy 
(ATR-FTIR) analysis of the coating was performed on an Avatar 380 (Thermo Nicolet) 
over a range of 800-1800 cm-1 at resolution of 2 cm-1 to study the chemical structure of 
the coating. ATR-FTIR testing was carried out with film samples assuming that coatings 
on both film and scaffolds were similar. The tested films were prepared by hot pressing 
PCL/TCP(Si) composite and followed by the same coating process as that with scaffolds. 
XPS (Thetaprobe from Thermo Scientific) was used to study the scaffold surface 
according to the method described in the materials and methods of chapter 4. 
5.2.5 Compression testing  
Compression testing of the scaffolds was conducted by using an Instron 4502 
uniaxial testing system according to the protocol described in the materials and methods 
of chapter 4. Compression testing was also carried out under simulated physiological 
condition by keeping the scaffolds at 37 ºC in phosphate buffer saline (PBS) solution for 
24 hours before testing. 
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5.2.6 Cell seeding on scaffolds 
Three groups of scaffolds were prepared namely, PCL/TCP(Si), PCL/TCP(Si)-CHA 
and PCL/TCP(Si)-CHA-gelatin and each scaffold was seeded with approximately 
1.8×105 BMSCs according to the protocol described in the materials and methods of part 
I chapter 4.  
5.2.7 Morphology of the cell-scaffolds constructs 
Confocal laser microscopy and SEM were used to assess cell viability, morphology 
and attachment in vitro as described in the materials and methods of part I chapter 4.  
5.2.8 PicoGreen® assay 
Proliferation of BMSCs in cell-scaffold constructs were studied using PicoGreen® 
assay as per manufacturer’s protocol (Molecular Probes, PicoGreen dsDNA Quantitation 
kit) was described in the materials and methods of part I chapter 4. 
5.2.9 Reverse transcription polymerase chain reaction (RT-PCR)  
Osteogenic gene expression of BMSCs at in vitro culture were analysed at day 17 
and 24. The protocol was described in the materials and methods of part I chapter 4. 
5.2.10 Western Blotting (WB) 
Osteogenic proteins of BMSCs at in vitro culture were analysed at day 17 and 24. 
The protocol was described in the materials and methods of part I chapter 4. 
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5.2.11 Statistical analysis 
An unpaired student’s t-test was performed to evaluate the significance of observed 
differences between the study groups. A value of p<0.05 was considered to be 
statistically significant. Data were tested for normality prior to performing the student’s 
t-test. 
5.3. Results and discussion 
5.3.1 Scaffolds fabrication 
In the present study bioresorbable PCL/TCP(Si) scaffolds were fabricated using 
SES with the following structural properties: i) 100% pore interconnectivity with pore 
size of ~500 μm; ii) scaffold porosity of 65%; and iii) 0º/60º/120º lay down pattern. The 
architectural layout of the developed scaffolds resembles the honeycomb which is 
advantageous over foam type structure. It has been reported that honeycomb structure 
allows bone ingrowths at later stages [164, 165], whereas foam structure limits tissue 
growth confined to the surface of the foam [166, 167]. 
5.3.2 Biomimetic CHA-gelatin composite coating 
In order to improve the osteoconductive property of additive manufactured 
PCL/TCP(Si) scaffolds, CHA-gelatin composite was coated onto additive manufactured 
PCL/TCP(Si) scaffolds through a facile biomimetic process. Scaffolds coated with CHA 
alone were also prepared to verify the improvement on the performance of scaffolds due 
to the incorporated gelatin. To promote biomimetic mineralization on the surface of 
PCL/TCP(Si) scaffolds in CHA coating or CHA-gelatin composite coating, CaHPO4 was 
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coated onto the scaffold first for inducing surface nucleation as reported previously 
[111]. In the preparation of CHA coated PCL/TCP(Si) scaffolds, the CaHPO4 coated 
PCL/TCP(Si) scaffolds were immersed into CH3COOH followed by simultaneously 
dropping CaCl2 and H3PO4 , and further dropping Na2CO3 according to the approach for 
CHA preparation as reported previously [168]. Due to the nucleation of CaHPO4, CHA 
was coated onto the PCL/TCP(Si) scaffolds.  As to CHA-gelatin composite coated 
PCL/TCP(Si) scaffolds (PCL/TCP(Si)-CHA-gelatin), the CaHPO4 coated PCL/TCP(Si) 
scaffolds were further coated with gelatin via electrostatic attraction between CaHPO4 
and gelatin by dipping into gelatin solution [169]. Finally, gelatin was co-precipitated 
with CHA on scaffold surface to produce CHA-gelatin composite coating via the 
biomimetic process similar as that for CHA coating. The carboxyl and amine groups 
present in the gelatin may become charged groups under the coating condition, such as –
COO- and –NH3+, which can promote CHA-gelatin composite nucleation. It should be 
noted that the whole approach is free from gelatin cross-linking. Thus, the potential 
toxicity caused by chemicals employed for cross-linking gelatin in other systems can be 
avoided [170, 171]. More interestingly, with the biomimetic approach described here, 
biomineralized coating can be achieved in a few hours. Figure 5.1 shows the flow 
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Figure 5.1 Flow diagram of the biomimetic composite coating process. 
5.3.3 Scaffold characterization 
PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds were 
characterized using SEM, ATR-FTIR and XPS. Compression testing was also conducted 
to determine whether there is any detrimental effect of the coating process on 
compressive modulus of the scaffolds.   
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The surface morphology of PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-
CHA-gelatin scaffolds was characterized by using SEM. As shown in Figure 5.2, while 
the PCL/TCP(Si) scaffolds exhibit smooth surfaces, both the PCL/TCP(Si)-CHA and 
PCL/TCP(Si)-CHA-gelatin scaffolds exhibit rough surfaces with uniform coating 
throughout. The CHA coating looks like globular apatite (Figure 5.2b) and CHA-gelatin 
composite coating looks like plate-like apatite (Figure 5.2c). The morphology difference 
between CHA coating and CHA-gelatin composite coating could be due to the presence 
of gelatin in the biomimetic co-precipitation for CHA-gelatin composite coating, as it is 
known that adsorption of protein on the mineral surface can alter the nucleation and 
growth of crystal in biomineralization [172]. The thickness of CHA coating and CHA-
gelatin composite coating are  measured as 702 ± 56 nm and 635 ± 119 nm from their 






Figure 5.3 SEM image of the cross-section of filament in (a) PCL/TCP(Si)-CHA and (b) 
PCL/TCP(Si)-CHA-gelatin scaffolds. 
 
635 ± 119 nm 
10 μm 
b a 
702 ± 56 nm 
10 μm 
  Chapter 5. 
95 
Figure 5.4 ATR-FTIR specta of (a) CHA and (b) CHA-gelatin composite coated 
PCL/TCP(si) film and FTIR spectra of (c) gelatin. 
 
The chemical structure of CHA-gelatin composite coating was studied using ATR-
FTIR. Figure 5.4 shows the FTIR spectrum of pure gelatin with the characteristic amide I 
and II bands at 1650 and 1550 cm-1, respectively. The observation of these characteristic 
amide bands of gelatin in the ATR-FTIR spectrum of CHA-gelatin composite coated 
PCL/TCP films reveals the presence of gelatin in the composite coating (Figure 5.4b). In 
the ATR-FTIR spectra of both CHA coated and CHA-gelatin composite coated 
PCL/TCP films, the characteristic bands for phosphate and carbonate groups were 
observed at 1039 cm-1 and 1400 cm-1, respectively, which are similar to those found in 
natural bone [150, 173]. This demonstrates the formation of CHA with bone like 
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Figure 5.5 XPS spectra of (a) PCL/TCP(Si); (b) PCL/TCP(Si)-CHA and (c) 
PCL/TCP(Si)-CHA-gelatin scaffolds. 
The chemical structure of the coating was also studied by using XPS.  No 
characteristic peak of calcium and phosphorous is detected in the XPS spectrum of 
PCL/TCP(Si) scaffolds as shown in Figure 5.5. This implies that ceramic particles of 
TCP(Si) are covered by PCL during composite preparation and/or scaffolds fabrication 
as reported previously [150]. In contrast, characteristic peaks of calcium and phosphate 
are observed in the XPS spectra of both PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-
gelatin scaffolds. Moreover, a nitrogen peak is detected in the XPS spectrum of 
PCL/TCP(Si)-CHA-gelatin scaffolds (Figure 5.5c). All these confirm the successful 
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Figure 5.6 Compression modulus (a) and compressive strength (b) of PCL/TCP(Si), 
PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds in dry and simulated 
physiological state.  
 
One of the basic functions of scaffolds for bone tissue engineering is to act as a 
supporting structure and provide adequate mechanical strength to maintain the spaces 
required for cell growth in physiological condition. The developed PCL/TCP(Si) 
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engineering application. However, compression testing on coated PCL/TCP(Si) scaffolds 
was carried out to evaluate whether there is any detrimental effect of the biomimetic 
coating process on mechanical properties. Compression testing in dry state and simulated 
physiological state revealed that PCL/TCP(Si)-CHA scaffolds and PCL/TCP(Si)-CHA-
gelatin scaffolds have almost the same mechanical properties like PCL/TCP(Si) scaffolds 
[Figure 5.6], which signifies no detrimental effect of coating process on mechanical 
properties of the PCL/TCP(Si) scaffolds both in dry state and simulated physiological 
state. 
5.3.4 In vitro cells response 
In this study, the proliferative and osteoconductive properties of the developed 
CHA-gelatin composite coating on PCL/TCP(Si) is evaluated by observing BMSCs 
morphology, proliferation, and gene and protein expression. Figure 5.7 shows the SEM 
images of BMSCs cultured on PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and 
PCL/TCP(Si)-CHA-gelatin scaffolds at day 7. Highest level of cells and cell-sheet 
accumulation were observed on PCL/TCP(Si)-CHA-gelatin scaffolds among all the 
scaffolds. Moreover, from the overview image of the PCL/TCP(Si)-CHA-gelatin 
scaffolds it can be seen that tissue bridges have started to form (indicated by arrow in 





Figure 5.7 SEM images of cell-scaffold construct of (a) PCL/TCP(Si), (b) PCL/TCP(Si)-
CHA and (c) PCL/TCP(Si)-CHA-gelatin scaffolds at day 7. The arrow shows the cells 
and/or cell-sheet accumulation that have spread on surface of the scaffolds. 
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Figure 5.8 SEM image of cell-scaffold construct of PCL/TCP(Si)-CHA-gelatin scaffolds 
at day 7. The arrow shows starting of tissue bridge formation. 
Figure 5.9 shows the confocal laser microscopy image of BMSCs cultured on 
PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds at different 
culture time. At day 7, BMSCs stretched well over the struts and distributed uniformly in 
PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds, while qualitatively fewer 
BMSCs were observed in non-coated PCL/TCP(Si) scaffolds. At day 10, PCL/TCP(Si)-
CHA-gelatin scaffolds exhibited tissue bridges between the struts (Figure 5.10) as well 
as the most uniform distribution of viable cells among all the scaffold groups (Figure 
5.9). In contrast, at day 10, the BMSCs seeded in PCL/TCP(Si) scaffolds were 
predominantly in round shape. It should be noted that our developed thin CHA-gelatin 
composite coating did not show any flaking tendency during cell culture as opposed to 
previous study [113], demonstrating excellent adhesion of the biomimetic composite 


















Figure 5.9 Confocal laser microscopy with depth projection images reconstructed from 
multiple horizontal images, showing 3D distribution of cells within the scaffolds of 






Figure 5.10 Confocal laser microscopy image of PCL/TCP(Si)-CHA-gelatin scaffolds at 
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Figure 5.11 PicoGreen® DNA quantification results of BMSCs cultured on 
PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds (*p<0.05).  
 
Figure 5.11 shows the proliferation of BMSCs in the cell-scaffold constructs studied 
by PicoGreen® assay. At all the time points, coated PCL/TCP(Si) scaffolds exhibit 
higher amount of DNA in comparison to non-coated PCL/TCP and PCL/TCP(Si) 
scaffolds. At day 7, PCL/TCP(Si)-CHA-gelatin scaffolds exhibit significantly higher 
amount of DNA in comparison to non-coated PCL/TCP(Si) scaffolds. At day 10, both 
PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds exhibit significantly higher 
amount of DNA in comparison to non-coated PCL/TCP(Si) scaffolds, and the  
significantly highest amount of DNA content is exhibited by PCL/TCP(Si)-CHA-gelatin 
scaffolds among all the scaffolds, with  1.4 and 2.0 times higher value than that of  
PCL/TCP(Si)-CHA and PCL/TCP(Si) scaffolds, respectively. These findings signify the 
highest level of BMSCs proliferation on PCL/TCP(Si)-CHA-gelatin scaffolds among all 
the scaffold groups, which could be due to the presence of gelatin in CHA-gelatin 




























Figure 5.12 mRNA expression of Cbfa1, Collagen I (Col1) and Osteocalcin (OCN) of 
BMSCs cultured for 17 days and 24 days on PCL/TCP(Si), PCL/TCP(Si)-CHA and 
PCL/TCP(Si)-CHA-gelatin scaffolds. 
The differentiation of BMSCs in the cell-scaffold constructs was studied by RT-
PCR analysis. The quantitative RT-PCR analysis (Figure 5.12) revealed that at day 17, 
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higher expression levels of Core binding factor α1 (Cbfa1) than that of PCL/TCP(Si) 
scaffolds, respectively. At day 24, which is a later time point, the Cbfa1 expression 
levels of PCL/TCP(Si)-CHA-gelatin and PCL/TCP(Si)-CHA scaffolds were 1.4 and 4.3 
times higher than  that of PCL/TCP(Si) scaffolds, respectively. Cbfa1 is considered as an 
important transcription factor for the commitment of multipotent mesenchymal cells into 
the osteoblastic lineage by triggering the gene expression of bone matrix proteins [138, 
139]. Cbfa1 retains the osteoblastic cells at an immature stage by hampering the 
transition of osteoblasts to osteocytes. Generally, the expression of Cbfa1 is first noticed 
in preosteoblasts, and up regulated in immature osteoblasts, but down regulated in 
mature osteoblasts [139, 174]. Cbfa1 is also involved in regulating bone phenotypic 
genes such as osteocalcin (OCN), one of the terminal differentiation markers [139, 175, 
176]. It can be seen from Figure 5.12, OCN is 25.2 and 9.8 times higher for 
PCL/TCP(Si)-CHA-gelatin and PCL/TCP(Si)-CHA scaffolds than that of the 
PCL/TCP(Si) scaffolds at day 24, respectively, when slightly lower expression level of 
Cbfa1 was observed. Expression of collagen I (Col1), which relates to further BMSCs 
differentiation to osteoblast, showed slightly basal expression levels for PCL/TCP(Si)-
CHA-gelatin and PCL/TCP(Si)-CHA scaffolds compared to PCL/TCP(Si). Down 
regulation of Col1 expression of marrow stromal cells (MSC) on hydroxyapatite after 
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proliferation, and biomineralization of extracellular matrix into bone. Its expression 
exhibits the commitment of BMSCs to osteogenic differentiation [178]. A significantly 
higher level (5.7 times) of OPN expression was observed on PCL/TCP(Si)-CHA-gelatin 
scaffolds compared to that on PCL/TCP(Si) scaffolds. At the same time, PCL/TCP(Si)-
CHA scaffolds showed 4.7 times of OPN expression compared to PCL/TCP(Si) 
scaffolds. Figure 12 also showed a higher amount of ON and OPN expression on 
PCL/TCP(Si)-CHA-gelatin scaffolds than that on PCL/TCP(Si)-CHA scaffolds. 
Stimulation of osteogenic differentiation of BMSCs on PCL/TCP(Si)-CHA-gelatin 
scaffolds may be due to the presence of gelatin in CHA-gelatin composite coating [179]. 
Previous study on collagen and HA showed that the addition of collagen to 
hydroxyapatite implants can enhance both phagocytotic and osteogenic processes [180]. 
These results suggest that CHA-gelatin composite coating on PCL/TCP(Si) scaffolds 
improved the proliferation and osteoconductive capability of the scaffolds significantly. 
5.4. Conclusions 
Additive manufactured PCL/TCP(Si) scaffolds with improved osteoconductive 
properties have been successfully prepared by coating with CHA-gelatin composite via a 
biomimetic co-precipitation process and was verified by XPS analysis. SEM and 
confocal images demonstrated the highest level of cells and cell-sheet accumulation with 
most uniform distribution on PCL/TCP(Si)-CHA-gelatin scaffolds compared to all other 
scaffolds. The proliferation rate of BMSCs on CHA-gelatin composite coated 
PCL/TCP(Si) scaffolds were 2.0 and 1.4 times higher that of PCL/TCP(Si) and CHA 
coated PCL/TCP(Si) scaffolds, respectively, by day 10. In vitro RT-PCR and western 
blotting testing showed highest level of osteoconductive property on PCL/TCP(Si)-
CHA-gelatin compared to all other scaffolds. These findings suggest that CHA-gelatin 
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composite coating is more effective than CHA coating on improving the proliferation 
and osteogenic differentiation of porcine BMSCs on additive manufactured scaffolds, 
which could be attributed to gelatin in the composite coating. This study provides a 
potential application of biomimetic composite coating on AM scaffolds. Consequently, 
the CHA-gelatin composite coated PCL/TCP(Si) scaffold could be regarded as a 
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Chapter 6 
Development of Additive Manufacturing-Freeze Drying 
Integrated Scaffolds with POSS modified PCL/TCP 
Scaffolds 
6.1 Introduction  
Though extrusion based AM technology is a promising, straight forward and low 
cost process which has been used to fabricate complex scaffold architecture designs with 
controlled pore size which eventually results in efficient nutrient perfusion [11, 12, 181], 
the scaffolds fabricated with this technology still pose a limit in cell seeding efficiency 
and tissue formation due to pore resolution. The pore size between the two consecutive 
strands is too large as compared to the dimension of the cells which eventually results in 
poor cell seeding efficiency. To solve this problem different research groups have 
incorporated electrospun fibre network within the pore of the additive manufactured 
scaffolds [16, 107, 108, 182]. In this approach additive manufactured scaffolds offers 
structural integrity and electrospun network within the pores works as a cell entrapment 
system [16]. However, combining electrospinning process with extrusion based additive 
manufacturing process to fabricate integrated macro and micro fiber scaffolds is not very 
simple. In this hybrid process AM and electrospinning are done in a repetitive manner 
which requires a special experimental setup. Moreover, effort is needed to insulate the 
additive manufacturing robot from the electrospinning high voltage collector. Therefore, 
a simpler process to fabricate this type of hierarchical scaffolds needs to be developed. 
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Freeze drying technology in conjunction with porogen method can be considered as 
an easy and diverse porous hydrogel foam preparation process and has been used in 
pharmaceutical [183] and tissue engineering fields [184-186]. In this approach water is 
used as a solvent and ice is used as a porogenic template. The inner porous structure of 
the freeze dried hydrogel can be controlled by varying the concentration of the solution 
and also by varying the freeze drying conditions e.g freezing temperature [184] and 
freezing rate [187]. Aligned porous structure can also be created by unidirectional freeze 
drying [186]. 
Gelatin, which is a denatured derivative of collagen, has a high number of biological 
functional groups and has been used to produce drug carriers, wound dressing materials 
and scaffolds for tissue engineering [184, 188-190]. Porous gelatin scaffolds have been 
successfully prepared by dissolving in water followed by freeze drying [184]. Therefore, 
to use the freeze drying process to create porous gelatin structure within the large pores 
of the additive manufactured scaffolds will make the process of fabricating hierarchical 
scaffolds simpler. 
Here, a novel route in fabricating hierarchical bone tissue engineering scaffolds has 
been designed with the combination and integration of AM and freeze drying 
technology. Firstly, POSS modified PCL/TCP composite was prepared, and then used to 
fabricate 3D porous extrusion based additive manufactured scaffolds. POSS modified 
PCL/TCP scaffolds have been shown earlier to provide significantly improved 
mechanical properties and are suitable to be used for cancellous bone tissue engineering 
application. Secondly, these 3D scaffolds were dipped into gelatin solution and porous 
gelatin structure was introduced within the pores of the 3D scaffolds through freeze 
drying. Porous gelatin structure has been cross-linked by using imide based zero-length 
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cross linker. Studies on cell-scaffold interaction were carried out by culturing rat bone 
marrow stromal cells (rBMSCs) on the scaffolds and assessing proliferation and 
differentiation. We hypothesize that the hierarchical scaffolds developed through this 
combinational approach will not only provide adequate mechanical properties but also 
improve the functional performance by improving cell seeding efficiency through the use 
of porous gelatin structure as a cell entrapment system. 
6.2 Materials and methods 
6.2.1 Materials  
Poly(ε-caprolactone) (PCL) (Mn: 80,000), GPTMS, gelatin (type A, from porcine skin), 
sodium hydroxide (NaOH),  acetic acid (CH3COOH) and 1-ethyl-3-(3-
dimehylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide 
(NHS) were purchaged from Sigma-Aldrich, Singapore. Tri-calcium phosphate (TCP) 
was purchaged from Progentix, The Netherlands. Tri silanollsobutyl POSS was 
purchaged from Hybrid Plastics, USA.  
6.2.2 Fabrication of POSS modified PCL/TCP scaffolds by SES 
POSS modified PCL/TCP composite was synthesized and PCL/TCP(POSS) 
scaffolds were fabricated according to the process described in chapter 4. Each layer of 
the scaffolds was fabricated with the designed pattern of 0º/60/º120º orientation. The size 
of the scaffolds used for the experiment was 5 mm × 5 mm × 3.5 mm. 
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6.2.3 Forming porous gelatin structure within the pores of the PCL/TCP(POSS) 
scaffolds and its characterization 
PCL/TCP(POSS) scaffolds were immersed in aqueous NaOH solution (10 ml, 5 M) 
at room temperature for 1 hour followed by through washing with de-ionized water. The 
NaOH treated scaffolds were dipped in CH3COOH (2 wt%) for 2 hours. The scaffolds 
were then dipped into 0.4 % (w/v) of gelatin solution for 2 hours at room temperature. 
Then the immersed scaffolds were freezed at -80 ºC for 24 hours, followed by freeze 
drying for 48 hours. The resulted porous gelatin structure within the 3D 
PCL/TCP(POSS)-foam scaffolds were cross-linked using an EDC/NHS agent based on 
the experimentally determined conditions: EDC (10 mL, 100 mM) and NHS (10 mL, 100 
mM) in 95% ethanol for 24 hours at 4 ºC. 
PCL/TCP(POSS) scaffolds with gelatin porous structure within the pores of it will 
be named as PCL/TCP(POSS)-foam scaffolds. 
6.2.4 Cell seeding on scaffolds 
Two groups of scaffolds were prepared namely, PCL/TCP(POSS) and 
PCL/TCP(POSS)-foam, and each scaffold was seeded with approximately 1.8×105 rat 
BMSCs according to the protocol described in the materials and methods of chapter 4.  
6.2.5 Morphology of the cell-scaffolds constructs 
SEM was used to assess cell morphology and attachment in vitro as described in the 
materials and methods of chapter 4.  
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6.2.6 PicoGreen® assay 
Proliferation of rat BMSCs in cell-scaffold constructs were studied using 
PicoGreen® assay as per manufacturer’s protocol (Molecular Probes, PicoGreen dsDNA 
Quantitation kit) was described in the materials and methods of chapter 4. 
6.2.7 Alkaline phosphate (ALP) activity 
The functional activity of the proliferated cells was examined by measuring the ALP 
activity expressed by the cells as described in the materials and methods of chapter 4. 
Five samples were collected for each time point from each group to ensure sufficient 
quantity of proteins for the assays.  
6.2.8 Statistical analysis 
All the data presented are expressed as mean ± standard deviation. An unpaired 
student’s t-test was used to test the significance level of the data. Differences were 
considered statistically significant at p<0.05. 
6.3 Results and discussions 
6.3.1 Fabrication of PCL/TCP(POSS) scaffolds by SES 
In order to prepare additive manufactured PCL/TCP scaffolds with adequate 
mechanical properties for cancellous bone tissue engineering, POSS was used to modify 
PCL/TCP composite as described in chapter 4. The prepared PCL/TCP(POSS) 
composite was used to fabricate scaffolds through an in-house screw extrusion system 
(SES). The fabricated scaffolds were 100% interconnected with pore size of 750-950 μm 
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and overall porosity of 65%. The compressive modulus and compressive strength of the 
fabricated PCL/TCP(POSS) scaffolds are 93.8 MPa and 6.02 MPa, respectively which 
fall within the range of mechanical properties of cancellous bone (50 – 500 MPa for 
compressive modulus and 3 – 12 MPa for compressive strength). Hence, 
PCL/TCP(POSS) scaffolds are suitable to be used for cancellous bone tissue engineering 
application. Moreover, on the surface of the PCL/TCP(POSS) scaffolds, exposed TCP 
was noticed, which eventually improves the biomimetic properties of the 
PCL/TCP(POSS) scaffolds compared to PCL/TCP scaffolds.    
6.3.2 Hierarchical PCL/TCP(POSS)-foam scaffolds to improve the functional 
performance of additive manufactured scaffolds 
PCL/TCP(POSS)-foam scaffolds were successfully produced by integrating two 
scaffold fabrication techniques: additive manufacturing and freeze drying technology. In 
this hierarchical structured scaffolds, additive manufactured PCL/TCP(POSS) structure 
provides adequate mechanical properties to be used in cancellous bone tissue engineering 
application. On the other hand, the porous gelatin foam structure created by freeze drying 
the gelatin solution acts as cell entrapment system during cell seeding, and thereby 
improves the functional performance of the additive manufactured scaffolds. 
 To facilitate the attachment between gelatin and the PCL/TCP(POSS) scaffolds, 
carboxyl group was introduced onto the surface of PCL/TCP(POSS) scaffolds by treating 
with NaOH and CH3COOH, respectively. Porous gelatin foam structure with different 
morphologies were created within the pores of the additive manufactured 
PCL/TCP(POSS) scaffolds by varying concentration of gelatin solution (Figure 6.1 and 
Figure 6.2). Porous gelatin foam structures formed at low concentrations of 0.1% and 
  Chapter 6. 
113 
0.2% (w/v) gelatin solution look unstable. The porous structure starts showing a definite 
pattern first at concentration of 0.3% (w/v). With the increase of gelatin concentration 
the pore size of the formed porous gelatin structure becomes smaller (Figure 6.2), and 
overall the structure becomes more packed (Figure 6.1). From the different groups of 
gelatin concentrations, porous gelatin foam structure with a concentration of 0.4% (w/v) 
gelatin has been chosen for further studies, assuming that the structure will entrapment 
cell, and at the same time as it is not densely packed it will not hinder nutrient flow 
within the pores of the scaffolds. This group will be denoted just as PCL/TCP(POSS)-








Figure 6.1 SEM images of overall PCL/TCP(POSS)-foam scaffolds with porous foam 
structure created with different concentrations of gelatin solution. The concentration of 
gelatin used was (a) 0.1% (w/v), (b) 0.2% (w/v), (c) 0.3% (w/v), (d) 0.4% (w/v), (e) 
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Figure 6.2 SEM images at higher magnification of PCL/TCP(POSS)-foam scaffolds 
showing morphology of porous foam structure with different concentrations of gelatin 
solution. The concentration of gelatin used was (a) 0.1% (w/v), (b) 0.2% (w/v), (c) 0.3% 
(w/v), (d) 0.4%  (w/v), (e) 0.5% (w/v) and (f) 0.6% (w/v).  
As gelatin is water soluble the stability of the formed porous gelatin foam structure 
was improved by using cross-linking. Gelatin can be cross-linked using several physical 
and chemical cross-linking approaches [191-193]. Physical methods which include de-
hydrothermal treatment and UV-irradiation are considered less efficient due to less 
control on the degree of crosslinking. Chemical crosslinking provides better control over 
the degree of crosslinking, and can be divided into non zero-length and zero-length 
cross-linkers. However, non-zero length crosslinkers may have an adverse effect in the 
body upon biodegradation of the hydrogel [192]. In this aspect zero length crosslinkers 
can be considered as they can facilitate crosslinking without incorporation of foreign 
structures into the network by activating carboxylic acid residues to react with free 
amine, resulting in the formation of an amide bond. In this experiment PCL/TCP(POSS)-
foam scaffolds were successfully cross-linked using a zero-length EDC/NHS agent based 
on the experimentally determined conditions [Figure 6.3]. The photograph image of 
PCL/TCP(POSS) and cross-linked PCL/TCP(POSS)-foam scaffolds has been shown in 
Figure 6.4. 
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Figure 6.3 SEM images of PCL/TCP(POSS)-foam scaffolds (a) before and (b) after 






Figure 6.4 Photograph image of PCL/TCP(POSS)-foam scaffold (left) and 
PCL/TCP(POSS) scaffold (right). 
6.3.3 In vitro cell response  
In this study, the proliferative and osteoconductive properties of the hierarchical 
scaffolds are evaluated by observing rat BMSCs morphology, proliferation and ALP 
expression. Figure 6.5 shows the SEM images of rat BMSCs cultured on 
PCL/TCP(POSS) and PCL/TCP(POSS)-foam scaffolds at day 14 and 21. For both of the 
time points higher levels of cells and cell-sheet accumulation were observed on 
PCL/TCP(POSS)-foam scaffolds compared to PCL/TCP(POSS) scaffolds. At day 14, 
cells on PCL/TCP(POSS) scaffolds showed good adherence to the scaffolds surface; on 
the other hand, the cells on PCL/TCP(POSS)-foam scaffolds showed not only good 
adherence but also a clear indication of cell-sheet accumulation. At day 21, the 
accumulation of cell-sheet on PCL/TCP(POSS)-foam scaffolds compared to 
PCL/TCP(POSS) scaffolds is more distinctive and prominent. Figure 6.6 shows the 
proliferation of BMSCs in the cell-scaffold constructs studied by PicoGreen® assay. At 
all the time points PCL/TCP(POSS)-foam scaffolds showed significantly higher amount 
100 μm 100 μm 
(a) (b) 
cm 
  Chapter 6. 
116 
of DNA in comparison to PCL/TCP(POSS) scaffolds. PCL/TCP(POSS)-foam scaffolds 
exhibit 2.6 and 3.5 times higher amount of DNA concentration compared to 
PCL/TCP(POSS) scaffolds at day 14 and day 3, respectively. 
The differentiation behaviour of cells on the scaffolds was evaluated by measuring 
the ALP activity of the cells on the scaffolds. ALP activity was measured as its study is 
straight forward and long been recognized [194]. As can be seen from Figure 6.7, the 
ALP activity of the cells on PCL/TCP(POSS)-foam scaffolds is significantly higher 
compared to that of PCL/TCP(POSS) scaffolds at all the time points. At day 14 and 28, 
the ALP activity of PCL/TCP(POSS)-foam scaffolds is 6.3 and 4.9 times higher 
compared to that of PCL/TCP(POSS) scaffolds, respectively.  
These in vitro results suggest that the porous gelatin foam structure significantly 














Figure 6.5 SEM images of cell-scaffold construct of PCL/TCP(POSS) and 
PCL/TCP(POSS)-foam scaffolds at day 14 and day 21. 
     PCL/TCP(POSS)             PCL/TCP(POSS)-foam 
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Figure 6.6 PicoGreen® DNA quantification results of rat BMSCs cultured on 
PCL/TCP(POSS) and PCL/TCP(POSS)-foam scaffolds (*p<0.05).  
 
Figure 6.7 Alkaline phosphate expression normalized to protein content of rat BMSC 
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6.4 Conclusions 
A novel PCL/TCP(POSS)-foam scaffold that combines the advantageous properties 
of AM scaffolds and porous foam scaffolds was developed. The successful integration of 
extrusion based AM and freeze drying technologies provides a platform to improve the 
functional performance of the AM scaffolds by providing a cell entrapment system. In 
the hierarchical structure of PCL/TCP(POSS)-foam scaffolds the macro-sized 
PCL/TCP(POSS) filaments provide adequate mechanical support for cancellous bone 
tissue engineering application. On the other hand the porous gelatin foam structure acts 
as a cell entrapment system, and there by improves the functional performance of the 
AM scaffolds. The in vitro SEM results showed notably higher level of cells and cell-
sheet accumulation on PCL/TCP(POSS)-foam scaffolds compared to PCL/TCP(POSS) 
scaffolds. The proliferation of BMSCs on PCL/TCP(POSS)-foam scaffolds was 
significantly higher compared to PCL/TCP(POSS) scaffolds. ALP activity was 5 times 
higher for PCL/TCP(POSS)-foam scaffolds compared to PCL/TCP(POSS) scaffolds at 
day 28. These in vitro results clearly showed the potential of PCL/TCP(POSS)-foam 
scaffolds for bone tissue engineering. Furthermore, the porous gelatin foam structure 
within the filaments of the scaffolds could also be used to supply specific gene and/or 
different biological factors, as gelatin has the potential to deliver different biological cues 
[188, 195, 196]. These hierarchical scaffolds could also be used to create different 
multifunctional 3D matrices that will improve the current status of tissue engineering 
applications [16].  
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Chapter 7 
In Vivo Evaluation of Apatite Coated Additive 
Manufactured Scaffolds in a Rat Calvarial Defect Model 
7.1 Introduction 
Development of appropriate synthetic bone graft or scaffold is becoming a key 
research topic in bone tissue engineering due the added advantages of synthetic bone 
graft over allograft and/or autogenous cancellous bone graft [3, 6, 123]. In this scaffold 
based bone tissue engineering approach, the scaffold acts as a temporary matrix to 
maintain, restore and improve the function of the damaged tissue by mimicking the 
mechanical and biochemical properties of the native tissue.  
To improve the mechanical and biochemical properties of the polymeric scaffolds 
pristine calcium phosphate ceramic particles have been mixed into the polymer directly 
[11, 12, 14, 128]. However, an important aspect which has been neglected in the context 
of bone tissue engineering is the interfacial properties between the ceramic and matrix 
phases [18], and therefore, limited improvement has been noticed on mechanical 
properties of polymer/ceramic composite scaffolds compared to polymeric scaffolds 
[15]. On the other hand, the masking of the ceramic particles by polymer during the 
blending process diminishes the proliferative and osteoconductive properties offered by 
ceramic particles [150]. Hence, to improve the proliferative and osteoconductive 
properties of polymer/ceramic composite scaffolds, mineralizing the scaffolds with a 
layer of apatite coating is considered an efficient approach. Comprehensive in vitro 
studies have been demonstrated the positive influence of biomimetic apatite coating on 
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the proliferative and osteoconductive properties of the synthetic scaffolds [128]. 
However, there are limited in vivo studies which justify the relevancy of biomimetic 
apatite coating on synthetic scaffolds. It should be noted here that clinically 
demineralized autograft and allograft bone is more useful than mineralized graft [197-
204]. Although, this is not necessarily the case when considering the clinical relevance of 
mineralization by biomimetic apatite coating on synthetic scaffolds, certainly more in 
vivo studies are needed to verify the clinical need of mineralization on synthetic 
scaffolds.  
In these contexts, to improve the mechanical properties of the polymer/ceramic 
composite scaffolds we have developed silanized poly-caprolactone/tricalcium phosphate 
(PCL/TCP(Si)) scaffolds, which has significantly improved mechanical properties 
compared to benchmark PCL/TCP scaffolds as described in chapter 4. Moreover, to 
improve the osteoconductive properties of the PCL/TCP(Si) scaffolds biomimetic 
coating was given on it  as also described in chapter 5. The developed biomimetic apatite 
coated PCL/TCP(Si) showed excellent mechanical properties and promising proliferative 
and osteoconductive properties in vitro, which eventually encourages us to initiate 
further in vivo study. 
Extrusion based AM technology fabricates scaffolds with honeycomb structure by 
laying down the screw extruded filaments in different directions [55]. The effect of 
different laydown patterns on this type of scaffolds has been conducted in terms of 
mechanical and in vitro characterization [28, 55, 205]; however, the effect of different 
lay down pattern in vivo has not been done yet.  
To address these issues, in the present study, we investigated the use of high 
performance extrusion based additive manufactured PCL/TCP(Si) scaffolds coated with 
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biomimetic apatite coating as an approach for optimizing the bone regenerative 
capabilities in the critical sized calvarial defect in rat model. We hypothesized that the 
scaffolds would provide a suitable substrate for cell proliferation and osteogenic 
differentiation in vivo. In conjunction with the two types of apatite coated scaffolds, 
namely carbonated hydroxyapatite (CHA) coated scaffolds and CHA-gelatin composite 
coated scaffolds; the effect of different lay down patterns of the scaffolds have also been 
investigated. 
7.2 Materials and methods 
7.2.1 Materials  
Poly(ε-caprolactone) (PCL) (Mn: 80,000), 3-glycidoxypropyl trimethoxysilane 
(GPTMS), gelatin (type A, from porcine skin),  acetic acid (CH3COOH), calcium 
chloride (CaCl2), potassium hydrophosphate (K2HPO4), phosphoric acid (H3PO4, 85% 
solution in water), sodium carbonate (Na2CO3) and sodium hydroxide (NaOH) were 
purchased from Sigma-Aldrich, Singapore. Tri-calcium phosphate (TCP) was purchased 
from Progentix, The Netherlands.   
7.2.2 PCL/TCP(Si) composite preparation and scaffolds fabrication 
PCL/TCP(Si) composite were synthesized, and subsequently PCL/TCP(Si) scaffolds 
were fabricated according to the process described in the materials and methods of 
chapter 4. In this experiment the scaffolds were fabricated with two different laydown 
pattern namely 0º/90º and 0º/60º/120º to study whether there is any effect of laydown 
pattern in vivo. The size of the scaffolds was 5 mm in diameter and 2 mm in thickness. 
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7.2.3 Biomimetic CHA and CHA-gelatin coating on PCL/TCP(Si) scaffolds 
The PCL/TCP(Si) scaffolds were coated with CHA and CHA-gelatin coating 
according to the process described in chapter 5. 
7.2.4 In vitro studies 
7.2.4.1 Cell seeding on scaffolds 
Four groups of scaffolds were prepared for in vitro study namely, PCL/TCP, 
PCL/TCP(Si),  PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin. The reason for 
including PCL/TCP scaffolds is just for a comparative evaluation with PCL/TCP(Si) 
scaffolds with rat BMSCs. Each scaffold was seeded with approximately 1.8×105 rat 
BMSCs according to the protocol described in the materials and methods of chapter 4.  
7.2.4.2 Morphology and viability study of the cell-scaffold constructs  
SEM and confocal imaging were used to assess cell morphology, viability and 
attachment in vitro as described in the materials and methods of chapter 4.  
7.2.4.3 ALP  
The functional activity of the proliferated cells was examined by measuring the ALP 
activity expressed by the cells as described in the materials and methods of chapter 4. 
Five samples were collected for each time point from each group to ensure sufficient 
quantity of proteins for the assays.  
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7.2.4.4 PicoGreen® Assay  
Proliferation of rat BMSCs in cell-scaffold constructs were studied using 
PicoGreen® assay as per manufacturer’s protocol (Molecular Probes, PicoGreen dsDNA 
Quantitation kit) was described in the materials and methods of chapter 4. 
7.2.5 In vivo studies 
7.2.5.1 Animal Surgery 
Twenty one skeletally-matured male Lewis rats were obtained from Animal 
Resources Centre, Canning Vale, WA. The rats were housed at the QUT Medical 
Engineering Research Facility (MERF) at the Prince Charles Hospital, Chermside. The 
animals received water and pelleted ration ad libitum throughout the experiment. The 
animal surgery and related in vivo characterizations were carried out by Prof Dietmar 
Hutmacher’s group at Institute of Health and Biomedical Innovation, Queensland 
University of Technology, Australia. 
7.2.5.2 Experimental design 
The rats were subjected to critical sized bone defects creation in their skull and 
implantation of PCL/TCP(Si) scaffolds coated with CHA and CHA-gelatin coating. 
Accordingly, the rats were assigned to four groups of six, as follows:  
Positive Control group: implantation of PCL/TCP(Si) scaffold (without surface 
modification)  
Negative Control group: the calvarial bone defects will be left empty.  
Treatment group I: implantation of PCL/TCP(Si)-CHA scaffolds.  
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Treatment group II: implantation of PCL/TCP(Si)-CHA-gelation scaffolds. 
Moreover, each scaffolds group consist two lay down pattern of 0º/90º and 
0º/60º/120º. 
7.2.5.3  Anesthesia and Pre-operative considerations 
All rats were operated under general anaesthesia. Buprenorphine (0.01 - 0.05, 
subcutaneously) were used pre-operatively for preemptive analgesia and post-operatively 
every 6-12 hour as pain killer. General anaesthesia was provided by using mixture of 
ketamine and xylazine (75-100 Ket + 5-10 Xyl, intraperitoneally in same syringe). Rats 
were handled briefly by hand for intraperitoneal injection of anaesthetic and then 
released into a separate cage until they become unconscious and ready for surgery. 
During anaesthesia, surgery and immediate post-operative period, the rats will were kept 
on a heating pad and after that, they were transferred to a clean warmed cage for 
recovery.  
The front parietal region was prepared by clipping hair with a delicate clipper and 
vigorous disinfection was achieved by application of chlorhexidine in alcohol solution. 
One dose of broad-spectrum antibiotic was given to the rats, immediately before surgery 
as for prophylaxis.  
7.2.5.4 Surgical procedure  
In order to produce critical size bone defects, a sagittal incision of approximately 20 
mm was performed over the scalp of the animal. A full-thickness bone defect (5 mm in 
diameter) was trephined in the centre of each parietal bone (two defects per calvarium) 
using a slow speed dental drill with irrigation to prevent heat damage of the host bone. 
While drilling down the bone, caution was taken not to damage the underlying exposed 
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dura mater at the bottom of the defect. A strip 2-mm wide of the marginal periosteum 
surrounding the defect was then removed. According to the implantation plan, both bone 
defects in each rat were implanted with one of the treatment modalities described above. 
Incisions were sutured and animals were allowed to recover for 12 weeks of post-
surgery, after which they were sacrificed by CO2 inhalation. To collect the implants, the 
skin was dissected, and the defect sites were removed along with the surrounding bone. 
The biopsied specimens were fixed and prepared for microCT analysis and mechanical 
testing.  
7.2.5.5  MicroCT 
At 3 months after surgery, in vivo mineralization within the constructs was 
quantified using a Micro-CT 40 scanner (Scanco Medical, Brüttisellen, Switzerland) at a 
voxel size of 36 μm. Samples were evaluated at a threshold of 220, a filter width of 0.8 
and filter support of 1.0. The data were volumetrically reconstructed using the 
reconstruction software from scanco. From the three-dimensional image, a cylindrical 
region of interest (ROI) of defect size of 5 mm diameter was selected for analysis. This 
ROI corresponds to the original defect location. X-ray attenuation was correlated to 
sample density using a standard curve generated by scanning hydroxyapatite phantoms 
with known mineral density. Mineralized matrix volume or bone volume fraction, and 
mineral density were quantified throughout the entire construct and presented as bone 
volume in mm3.  
7.2.5.6 Mechanical testing 
After sacrifice, the rat calvaria were retrieved, wrapped in wet gauze and stored at -
20 ºC until analysis. Upon thawing, the calvaria were potted in a Petri dish with 
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polymethylmethacrylate (Meliodent Rapid Repair, Heraeus Kulzer) to enable stable 
fixation for the mechanical testing. Non-destructive micro-compression on the calvaria 
defects was performed using a Micro Tester 5848 (Instron) with a 10-N load cell. An 
indenter probe of 0.5 mm diameter was micro-fabricated for the test. Micro-
compressions of up to 50% strain were conducted at an average of eight different 
locations on each defect site, and the load-displacement and stiffness (compression 
modulus) were determined. The probe locations were identified to be the pore spaces 
(between the scaffold struts) of the constructs so as to measure the modulus of 
regenerated tissue rather than scaffold material. Push-out tests were conducted to 
evaluate the functional mechanical integration of the tissue-engineered constructs into 
the host calvaria, and were performed on the Micro Tester 5848 (Instron) with a 1-kN 
load cell [206, 207]. An indenter probe of 4.5 mm diameter, slightly smaller than the 
scaffold diameter of 5 mm, was fabricated for the test. After the micro-compression tests 
were completed, the calvarial specimens were tested to failure and the final yield was 
determined. Four to eight specimens were used for each group. Intact rat calvaria were 
also used as controls. 
7.2.6 Statistical analysis 
Statistical analysis was performed for all the quantitative results using Student’s t-
test for comparing means from two independent sample groups. A confidence level of 
95% was used (p< 0.05). 
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7.3 Results and discussions 
7.3.1 PCL/TCP(Si) composite preparation, scaffolds fabrication and biomimetic 
coating on scaffolds 
To improve the mechanical properties of the additive manufactured PCL/TCP 
scaffolds, interfacial bonding between PCL and TCP was enhanced by modifying TCP 
using GPTMS as a coupling agent. PCL/TCP(Si) scaffolds were fabricated from the 
synthesized PCL/TCP(Si) composite using an in house SES. In this study, the fabricated 
scaffolds were 100% interconnected with porosity of 67% and 71% for 0º/60º/120º and 
0º/90º patterned scaffolds, respectively. 
On the other hand, in order to improve the osteoconductive property of 
PCL/TCP(Si) scaffolds, biomimetic CHA and CHA-gelatin were coated onto 
PCL/TCP(Si) scaffolds through a facile biomimetic process. The detailed mechanism 
and characterization of the PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-gelatin 
scaffolds have been discussed in the results and discussion section of chapter 5. 
7.3.2 In vitro studies 
In this study, the proliferative and osteoconductive properties of the prepared 
scaffolds are evaluated by observing rat BMSCs morphology, proliferation, and ALP 
expression. In the in vitro studies the objective was to evaluate the coated scaffolds. 
Scaffolds with different laydown pattern were not tested in vitro, as no difference has 
been noticed from the previous study of the senior author’s group [55]. 
 Figure 7.1 shows the confocal laser microscopy image of rBMSCs cultured on 
PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds 
  Chapter 7. 
128 
at different culture time. At both day 7 and day 14, BMSCs stretched well over the struts 
and distributed in PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds, while 
qualitatively fewer BMSCs were observed in non-coated PCL/TCP and PCL/TCP(Si) 
scaffolds.  
Figure 7.2 shows the proliferation of rBMSCs in the cell-scaffold constructs studied 
by PicoGreen® assay. At all the time points, both the CHA coated and CHA-gelatin 
composite coated PCL/TCP(Si) scaffolds exhibit higher amount of DNA in comparison 
to non-coated PCL/TCP and PCL/TCP(Si) scaffolds. At all the time points 
PCL/TCP(Si)-CHA-gelatin scaffolds exhibit significantly higher amount of DNA in 
comparison to non-coated PCL/TCP(Si) scaffolds. At day 14, PCL/TCP(Si)-CHA 
scaffolds exhibit higher amount of DNA in comparison to non-coated PCL/TCP and 
PCL/TCP(Si) scaffolds, whereas  PCL/TCP(Si)-CHA scaffolds exhibit higher amount of 








Figure 7.1 Confocal laser microscopy with depth projection images reconstructed from 
multiple horizontal images shows 3D distribution of cells within the scaffolds of 
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Figure 7.2 PicoGreen® DNA quantification results of BMSCs cultured on PCL/TCP, 
PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds (*p<0.05).  
 ALP is a biomarker of osteogenic differentiation; hence its expression indicates 
differentiation of rBMSCs down the osteoblast lineage. As can be seen from Figure 7.3, 
all the scaffolds demonstrated a steady growth in ALP activity. For all the time points 
PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin showed higher level of ALP activity  
compared to PCL/TCP and PCL/TCP(Si) scaffolds. It should also be noted here that no 
difference between CHA coating and CHA-gelatin composite coating have been noticed.  
From the in vitro results it can be said that CHA coated and CHA-gelatin composite 
coated scaffolds have greater potential compared to non-coated scaffolds. In the 
following section in vivo effect of the coatings will be discussed. Moreover, different 

































Figure 7.3 Alkaline phosphatase expression normalized to protein content of rMSC 
cultured on PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-
gelatin scaffolds.  
7.3.3 In vivo studies 
7.3.3.1 Animal surgery 
Critical size bone defects were created in the scull, and the scaffolds were implanted 
inside the scaffolds as shown in Figure 7.4. After 12 weeks, the animals of all groups 
were euthanized and the specimens were removed along with surrounding bone for 
further evaluations. No wound infection appeared during the experiment, and all the 
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7.3.3.3 Mechanical testing 
To test the mechanical integrity of the newly formed tissue within the scaffold pore 
space, micro-compression was performed on harvested calvaria at 8 different locations 
within pore spaces of each scaffold (Figure 7.8).  
All defects, treated with PCL/TCP(Si)-Scaffolds with a 0/90° configuration of the 
fibers showed a higher stiffness and compared to the PCL/TCP(Si)-0/60°-Scaffolds 
(Figure 7.9). The tissue stiffness of the PCL/TCP-(si)-0/90° and the PCL/TCP-(si)-CHA-
0/90° were comparable to that of intact bone (Figure 7.9A). The defects treated with 
PCL/TCP-(si)-CHA-gelatin-0/60° and 0/90°-Scaffolds showed significant lower stiffness 
compared to all the other experimental groups. The push-out tests were performed to 
evaluate the mechanical integration of the constructs with the host calvaria (Figure 
7.9B), an important aspect from acraniofacial treatment point of view. After 12 weeks, 
the defects treated with PCL/TCP-(si)-0/90° Scaffolds, showed a similar push-out 
strengh as that of host bone tissue, suggesting new bone was forming from the periphery 
of the defect edges and encouraging integration of the implant within the defect site 
(Figure 7.9B). The PCL-TCP(Si) scaffolds with the 0º/90° configuration of the fibers 
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Figure 7.9 Micro-compression tests and push out tests were performed after 12 weeks. 
Stiffness (A) and Load of fracture (B) are reported here. Regenerated tissue within the 
PCL/TCP-(si)-0/90°-Scaffold group and the mPCL/TCP-(si)-CHA-0/90°- Scaffold group 
showed superior stiffness and the highest push-out strength of all experimental groups. 
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 7.4 Conclusions 
In this study additive manufactured PCL/TCP(Si) scaffolds coated with apatite were 
evaluated in vivo. The surface coated scaffolds showed excellent results in vitro but not 
significantly distinct results in vivo, which eventually highlight the complexity in 
translating in vitro findings into the clinical arena and the undoubted importance of in 
vivo study. Along with the effect of surface modification, the effect of the lay down 
pattern of the scaffolds’ was also evaluated. For each experimental group of coated and 
non-coated scaffolds, the fibre configuration was 0º/90° and 0º/60°/120º. To our 
knowledge, no other group reported any study in bone regeneration, regarding the 
alignment of the struts. The experimental groups with the 0º/90° fibres alignment showed 
a significantly higher bone regeneration potential compared to the 0º/60° scaffold group, 
in respect of the newly formed bone matrix, the stiffness of the bone matrix and the 
maximum load of fracture. In the 0º/90° scaffold group, a better incorporation of cells 
from the host, as well as a better supply of nutrients might be reasons for this improved 
bone regeneration. This study demonstrated that a surface modification of PCL/TCP(Si) 
scaffolds can influence their regenerative potential for bone tissue engineering 
applications. Beside the surface modification, the alignment of the scaffold fibres 
influences the bone regeneration potential of the scaffolds. A 0º/90°-alignment of the 
scaffold fibres showed a better regeneration of bone tissue.  
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Chapter 8 
Conclusions and Recommendations 
8.1 Conclusions 
This research was initiated with the development of polymer/ceramic composites 
with improved interfacial interaction by the use of different coupling agents. Additive 
manufactured (AM) scaffolds were fabricated with the developed polymer/ceramic 
composite using an in-house screw extrusion system (SES), and subsequently 
characterized. The developed scaffolds were further modified to improve the 
osteoconductive properties and cell entrapment efficiency. The scaffolds were 
characterized through different physical characterizations, and as well as in-vitro 
characterizations. The conclusions and significance of this research project are 
summarized under the following headings: 
 Improvement of the mechanical properties of the additive manufactured 
scaffolds. 
 Improvement of the proliferative and osteoconductive properties of the 
additive manufactured scaffolds. 
 Improvement of the functional performance of the additive manufactured 
scaffolds. 
 Evaluation of the biomimetic composite coated additive manufactured 
scaffolds in vivo. 
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8.1.1 Improvement of the mechanical properties of the additive manufactured 
scaffolds 
To improve the mechanical properties of the scaffolds two different coupling agents, 
namely silane and POSS have been used in this research project. The main idea of using 
a coupling agent was to improve the interfacial interaction between the ceramic and 
polymer phase.  
The developed silanized PCL/TCP scaffolds showed 6 times higher compressive 
modulus and 2.3 times higher compressive strength than those of PCL/TCP scaffolds; 
and the values fall within the lower range values of cancellous bone. In vitro confocal 
images showed homogenous BMSCs distribution on GPTMS modified PCL/TCP 
scaffolds. PicoGreen® data showed that proliferation rate of BMSCs on modified 
PCL/TCP scaffolds was equally as good as unmodified PCL/TCP scaffolds. The over all 
in vitro BMSCs culture signifies that there is no detrimental effect of GPTMS on cells’ 
viability and proliferation.  
The POSS modified PCL/TCP scaffolds showed 6.8 times higher compressive 
modulus and 3.4 times higher compressive strength than those of PCL/TCP scaffolds. 
Notably the compressive modulus and compressive strength of the native cancellous 
bone are 93.8 MPa and 6 MPa, respectively, and thus mechanical properties of POSS 
modified PCL/TCP scaffolds falls within the lower range of those of cancellous bone. 
Moreover, the SEM observation of POSS modified PCL/TCP scaffolds showed exposed 
TCP particles on the surface of the scaffolds. The exposed TCP was verified by XPS. 
This result is also significant, since a common problem in polymer/ceramic scaffolds is 
the covering up of ceramic particles by polymer matrix. The exposed TCP on the POSS 
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modified PCL/TCP scaffolds help to improve the proliferative capability of the scaffolds 
as shown by SEM and confocal images.  
The use of coupling agent to improve the interfacial interaction between the ceramic 
and polymer phase has long been ignored in the development process of composite 
material for bone TE scaffolds. Hence, this study is remarkably significant as it shows a 
new perspective to modify scaffolds for better mechanical properties.     
8.1.2 Improvement of the proliferative and osteoconductive properties of the 
additive manufactured scaffolds 
In order to improve the proliferative and osteoconductive properties, PCL/TCP(Si) 
scaffolds were coated with carbonated hydroxyapatite (CHA)-gelatin composite by 
biomimetic co-precipitation process. The successful incorporation of CHA-gelatin 
composite coating was verified by SEM and XPS analysis. It should be noted that cells 
attached to and growing on the bars of additive manufactured scaffolds experience 
different mechanical constraints in comparison with other types of scaffolds. Coatings on 
the bars of the additive manufactured scaffolds experience tensile forces due to the free 
tissue bridges and thus flaking of the coating layer occurs. In this aspect a thin layer of 
composite coating is desirable. The thickness of developed CHA-gelatin composite 
coating was 650 nm and developed thin coating did not show any flaking phenomenon 
on the bars of the additive manufactured PCL/TCP(Si) scaffolds during BMSCs culture. 
SEM and confocal images demonstrated notably high levels of cells and cell-sheet 
accumulation with uniform distribution on PCL/TCP(Si)-CHA-gelatin scaffolds 
compared to PCL/TCP(Si) scaffolds. The proliferation rate of BMSCs on PCL/TCP(Si)-
CHA-gelatin scaffolds was 2.0 times higher than that of PCL/TCP(Si) scaffolds, 
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respectively, by day 10. In vitro RT-PCR and western blotting testing showed higher 
level of osteoconductive property on PCL/TCP(Si)-CHA-gelatin compared to 
PCL/TCP(Si) scaffolds. Thus, this study is quite significant as it provides a new 
perspective to the potential of biomimetic composite coating on additive manufactured 
scaffolds.   
8.1.3 Improvement of the functional performance of the additive manufactured 
scaffolds 
To improve the functional performance of the AM scaffolds by providing a cell 
entrapment system, a novel PCL/TCP(POSS)-foam scaffold that combines the 
advantageous properties of AM scaffold and porous foam scaffold was developed. In the 
hierarchical structure of PCL/TCP(POSS)-foam scaffolds the macro-sized 
PCL/TCP(POSS) filaments provide mechanical support and the porous gelatin foam 
structure acts as a cell entrapment system. From the manufacturing point of view, to 
fabricate hierarchical scaffolds, our developed approach is considerably simpler than 
combining electrospinning with AM. In vitro SEM results showed notably higher level 
of cells and cell-sheet accumulation on PCL/TCP(POSS)-foam scaffolds compared to 
PCL/TCP(POSS) scaffolds. The proliferation of BMSCs on PCL/TCP(POSS)-foam 
scaffolds was also significantly higher compared to PCL/TCP(POSS) scaffolds. ALP 
activity was 5 times higher for PCL/TCP(POSS)-foam scaffolds compared to 
PCL/TCP(POSS) scaffolds at day 28. These in vitro results clearly showed the potential 
of PCL/TCP(POSS)-foam scaffolds for bone tissue engineering. From all the findings it 
can be claimed that this study provides an efficient alternative to fabricate hierarchical 
scaffolds with improved functional performance for bone tissue engineering.  
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8.1.4 Evaluation of the biomimetic composite coated additive manufactured 
scaffolds in vivo 
The study is a collaborative work with Prof Dietmar Hutmacher’s group at Institute 
of Health and Biomedical Innovation, Queensland University of Technology (QUT), 
Australia. The scaffolds fabrication and in vitro characterizations were done at NUS, 
whereas the animal surgery and in vivo characterizations were done at QUT. This study 
evaluates the bone regeneration capabilities of additive manufactured PCL/TCP(Si) 
scaffolds coated with biomimetic apatite coating in the critical sized calvarial defect of 
an animal model. Moreover, two different lay down patterns, namely, 0º/90° and 
0º/60°/120º of the scaffolds were also investigated in the animal model. The results 
showed that a surface modification of PCL/TCP(Si) scaffolds can influence their 
regenerative potential for bone tissue engineering applications. However, despite the 
excellent results in vitro, the in vivo performance of the coated scaffolds was not 
significantly higher compared to non-coated scaffolds, which eventually highlight the 
complexity in translating in vitro findings into the clinical arena and justifies the 
undoubted importance of in vivo study. On the other hand, all the experimental groups 
with the 0º/90° fibres alignment either coated or non-coated showed a significantly 
higher bone regeneration potential compared to the 0º/60° scaffold group, with respect of 
the newly formed bone matrix, the stiffness of the bone matrix and the maximum load of 
fracture. In the 0º/90° scaffolds group, a better incorporation of cells from the host, as 
well as a better supply of nutrients might be reasons for better bone regeneration. This 
study signifies that the alignment of the scaffolds’ fibres influence the bone regeneration 
potential of the scaffolds in vivo. To our knowledge this is the first reported study on in 
vivo bone regeneration regarding the alignment of the struts. 
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8.2 Limitations and recommendations  
This research focused on the improvement of mechanical and functional 
performance of the additive manufactured scaffolds for bone tissue engineering. Though 
significant results were achieved, future research should address the following 
limitations: 
 This study focused only on PCL based composite, PCL/TCP, and did not 
explore other composites based on PLGA or PLLA polymer.  The reason 
for this focus on only PCL based composite is acceptable, as it is known 
that the chemistry which is true for PCL is also true for other aliphatic 
polyester based polymers like PLGA and PLLA.  However, in terms of 
mechanical properties PLGA and PLLA are superior compared to PCL. 
Therefore, future studies should attempt to use other mechanically stronger 
polymers instead of PCL to get the required mechanical properties of both 
cancellous and cortical bone. 
 The successful regeneration of tissue largely depends on how tissue 
replacing the biodegradable scaffolds. This process is executed via 
controlled transfer of load or function back to the host tissue as the scaffolds 
degrade and resorb. Therefore, the study of degradation kinetics of the 
developed silanized and POSS modified PCL/TCP scaffolds could be next 
phase of study.  
 Apatite coating on the scaffolds can be used to deliver proteins and/or 
growth factors. 
 Porous gelatin foam structure within the filaments of the scaffolds could 
also be used to supply specific gene and/or different biological factors, as 
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gelatin has the potential to deliver different biological cues. The hierarchical 
scaffolds could also be used to create different multifunctional three 
dimensional matrices that will improve the current status of tissue 
engineering applications. 
 Extensive animal study on these scaffolds is highly recommended. 
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Improving the Mechanical Properties in Tissue Engineered 
Scaffolds 
A.1 Introduction 
Many patients who are in need of organ transplants suffer greatly and may even die 
from the lack of suitable donors with the demand for artificial organs far exceeding 
supply.  In addition, bone grafting procedures are routinely carried out on a daily basis.  
Such bone grafts would not be required should there be satisfactory replacement bones. 
Scaffold-based tissue engineering aims to aid in the repair and regeneration of bone 
defects.  Using this approach, scaffolds act as platforms that carry cells or therapeutic 
agents for regenerative therapies.  To effectively achieve this, the scaffold should be 
osteoconductive, osteoinductive, biodegradable, highly porous and should have suitable 
mechanical properties and surface chemistry. To date, scaffold structures have only been 
used with some success in low-load bearing applications, despite the large variety of 
biomaterials and fabrication techniques explored in the last two decades.   
Poly (ε-caprolactone) (PCL) is a semicrystalline, bioresorbable polymer 
belonging to the aliphatic polyester family. Its melting temperature is 60ºC [3].  PCL has 
been used to make three-dimensional porous scaffolds, with a fully interconnected pore 
network, using Fused Deposition Modeling (FDM).     β-Tricalcium phosphate (β-TCP) 
is a bioactive and biocompatible ceramic that has the ability to bind directly to bones.  It 
has been used widely in orthopedic and dental applications due to its solubility and bone 
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remodeling capabilities.  Composites including PCL-TCP are presently being used 
extensively as they have the suitable properties of both the polymer and ceramic.  Recent 
studies show the suitability of PCL-20%  β-TCP scaffolds fabricated by FDM for low-
load bearing bone tissue engineering applications. 
 In this study, we demonstrate the possibility of increasing the mechanical 
properties of such scaffolds by introducing a through-hole.  A number of scaffolds with 
through-holes of various sizes were fabricated in order to study the effect of the through-
hole diameter on the stiffness of the complete scaffold.  As well as possibly improving 
the mechanical properties of a scaffold, it is conjectured that through-holes may also 
become useful for the channeling or storage of nutrients. 
A.2 Materials and methods 
A.2.1 Scaffold processing 
A.2.1.1 Scaffold Material:  
For experiments we used PCL-20% β-TCP biocomposite.  The composite was 
prepared by combining the PCL polymer and β-TCP in methylene chloride (JT Baker).  
The distribution of β-TCP within the composite was assessed and ensured to be 
homogeneous by visual inspection and analyzed using a microcomputed tomography (μ-
CT) machine (Skyscan1076, Belgium). 
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A.2.1.2 Scaffold Fabrication:  
In house screw-extrusion system (SES) has been used to fabricate the scaffolds.  
Once the material is fed into the SES, the material melts to a semi-liquid state. The semi-
liquid material is then extruded through the nozzle due to pressure created by screw 
rotation. The extruded material is deposited in layers in a similar way to the commercial 
FDM process. The material solidifies and bonds to the preceding layer. After a layer is 
completed, the height of the extrusion head is increased and the subsequent layers are 
built to construct the entire scaffold. 
The SES was used to fabricate scaffolds with 0/90o lay down pattern and bulk 
dimension of 30 mm * 30 mm * 7 mm.  During the fabrication the processing 
temperature was set at 85 oC, the filament separation distance (centre to centre horizontal 
distance between adjacent filaments) was set to 1.5 mm and the nozzle diameter 0.5 mm.  
After the scaffolds were fabricated, through holes were drilled and subsequently 
scaffolds were cut into 6 mm *6 mm * 7 mm dimensions for analysis.  The through holes 
were drilled because this technique was considered to be the simplest method for 
incorporating a sealed through hole into this type of scaffold.  To study the relationship 
between hole size and strength, drill bits of 1.3 mm, 1.5 mm, 1.8 mm, 2.0 mm, 2.3 mm 
sizes were used. 
A.2.2 Morphology study by SEM  
Scaffold morphology and pore size were studied by using Scanning Electron 
Microscopy (SEM).  Scaffolds were gold sputter coated by using a JEOL fine sputter 
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coater (JFC-1200) for 90 seconds at 10 mA. The SME images were taken by Philips 
XL30 FEG at a beam intensity of 10 kV. 
A.2.3 Mechanical characterization  
Compression tests were conducted on scaffolds by using an Instron 4502 Uniaxial 
testing system and 5kN load cell (Canton, MA, USA).  From every batch five samples 
were tested adopting the guidelines for compression testing of acrylic bone cement set in 
ASTM F451-99a.  The scaffolds were compressed at a rate of 1 mm/min up to a strain 
level of approximately 80%.  The stress-strain (σ-ε) curves were obtained to evaluate the 
compressive modulus.  The modulus was calculated from the stress-strain curve as the 
slope of the initial linear portion of the curve. 
A.3 Results 
A.3.1 Scaffold morphology 
Figure 2 shows SEM images of scaffolds with different sizes of drilled hole. It can 
be seen from the figure that, at the wall of the larger holes, a greater amount of material 
has been melted by the drill bit during drilling. 
A.3.2 Mechanical properties of the scaffolds  
 The stiffness of scaffolds with different hole size is given in Table 1.  The effect 
of the diameter of the holes on the stiffness of the scaffolds is given in Figure 3.  Table 1 
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and figure 3 show an increase of about 37% in stiffness for scaffolds with hole diameter 










Fig. A-1: SEM images of the scaffolds. 
 
Table A-1: Calculated compressive stiffness for the scaffolds with different hold 
diameter. 
 
Diameter of hole (mm) Stiffness (MPa) 
Without hole 25.86 ± 1.09 
1.3 22.74 ± 1.3 
1.5 27.61 ± 1.14 
1.8 27.65 ± 1.56 
2.0 34.29 ± 0.55 
















Fig. A-2: Effect of the hold size diameter on the stiffness of the scaffold. 
A.4 Discussions 
 Table A-1 and Figure A-2 show that for the smaller diameter hole the effect on 
stiffness is negative.  After this we appear to get a threshold value for the hole diameter.  
Finally, there is noteworthy increment in the stiffness for the larger hole diameter.  
The stiffness of the scaffold with hole diameter 1.3mm is lower than that of the 
scaffolds without hole.  For the 1.5 mm hole diameter the difference in stiffness is also 
not remarkable.  Therefore, it can be said that hole diameter smaller than the filament 
separation distance has negative impact on the stiffness of the scaffolds.  This may be 
because, for a smaller diameter hole, the structure is damaged during the hole making 
process. Evidence of this can be observed in the developed micro cracks as shown in 
Figure A-3.  
It should be noted that for 1.5 mm hole and for 1.8 mm hole we observed only a 
6.9% increment in stiffness. However, a large change in stiffness was found for 2.0mm 
hole diameter.  For 2.0 mm and 2.3 mm hole diameters, the stiffness increases by 32.6% 
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that 1.8mm diameter hole acts as a threshold value for 1.5 mm filament distance and hole 
diameters larger than the filament distance have significant effect on the stiffness of the 
scaffold.  From Figure A-4, it can be seen that larger diameter drilled holes involve more 
material in the column making process.  As the amount of fused material is more for the 
larger hole diameter, the strength of the scaffold has increased correspondingly.  It can 
be seen clearly that the holes mask off the interconnected pores in the remainder of the 
scaffold.  Such columns can act as a means for storing nutrients or for channeling flow 
through the scaffold.  The number and distribution of the columns must therefore be 
limited in relation to the remainder of the scaffold, but nonetheless can be an important 










Fig. A-4: Molten material acts as a column and increases the strength of the scaffold. 

















 This experiment demonstrated the possibility of increasing the mechanical 
properties of the PCL-20% β-TCP scaffolds by making a through hole. From the 
experiment we can conclude that, for a specific filament distance there is a threshold 
value of the hole diameter.  A hole larger than that of the threshold value has a 
significant impact on increasing the strength of the scaffold.  In addition it is 
believed, this column type hole can also be useful for channeling or storage of 
nutrients.  By using this through hole for nutrient storage we can make scaffolds 
more suitable for load bearing application without decreasing the effectiveness for 
tissue regeneration.  Future study may investigate how to incorporate through-hole 
into the direct fabrication process. 
 
 
